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Osteoarthritis (OA) is an age-related chronic condition and the most 
frequent cause of musculoskeletal disability in developed countries, 
resulting in limited activities of daily living among the general 
adult populationY Although OA may affect any joint of the body, 
it most commonly affects the knee, followed closely by the hip. 3 
The two main categories of hip OA are primary hip OA ( also termed 
idiopathic)and secondary hip OA (from a known cause). Primary 
hip OA is believed to account for the majority of all hip OA.4 
The prevalence of primary radiographic hip osteoarthritis in the 
United States was 27% in the year 2003 for adults over 45 years of age. In 
the Netherlands this prevalence in 2004 was 7.0% for adults aged over 55.5 
Due to an aging society and the epidemic of obesity6 •7 in the Western world, 8 
the number of people developing hip osteoarthritis is expected to increase. 
In the United States it has been estimated that the prevalence of people with 
OA of the hip will increase from 43 million in 1997 to 60 million in 2020.9 
An increase in the prevalence of hip OA cases is estimated 
for the Netherlands too. 10 
Conservative, e.g. non-surgical, treatment options for OA of the 
hip are available and described in international guidelines11-13 that advise 
losing weight as well as increasing activity. However, the hip OA guide­
lines are predominantly based on knee OA research and to a lesser extent 
on hip OA research. In the Netherlands there are national guidelines for the 
treatment of hip and knee OA 14 which in fact resemble the international 
guidelines. No specific guidelines are available for the general practitioner 
(GP) setting though. This is a major disadvantage, as general practitioners 
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act as gatekeepers for medical care. To that end it is interesting to know 
what kind of treatment a patient with hip OA receives in his initial contact 
moments with the general practitioner, and more specifically if the GP 
incorporates weight loss and/ or exercise into the treatment plan. There is 
some literature providing information on GPs' general management of pa­
tients with hip complaints, 15• 16 yet specific information with respect to 
treatment of hip OA is lacking. The first objective of this thesis is there­
fore to study the treatment policy of the general practitioner, and more 
specifically to what extent weight loss and/ or exercise play a role in the 
conservative treatment of OA of the hip. 
Regarding weight loss as a treatment option, a reduction of 
10% of body weight over 18 months in older adults has been shown to 
significantly reduce joint loads in knee OA patients.17 While increasing 
activity plays an additional role in losing weight, the combination of these two 
is analysed for its effect in knee OA patients, with a supplemental result: a 
combination of weight loss and exercise is more effective in improving 
self-reported physical function compared to either of them alone. 18 According to 
the above it is generally accepted that such a combination treatment will have an 
analogue effect in hip OA patients, but this remains speculative as no re­
search has determined this yet. The second objective of this thesis is thus to 
study the effect of a combination treatment of weight loss and exercise in 
hip OA patients. 
While hip OA is a degenerative disease, total hip joint replacement 
(THA) is the last treatment modality for advanced disease. Once a THA 
has been performed, overweight/ obesity still plays an important role, as 
overweight/ obesity is associated with a negative effect on functional 
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outcome after THA and on implant longevity. 19 Studies have also found a 
correlation between overweight/ obesity and higher infection rates, risk of 
dislocation and aseptic loosening, 20-23 yet few have taken the influence of 
comorbidity and complications into account when assessing the influence of 
overweight/ obesity on the outcome after THA. 24 The third objective of this 
thesis is therefore to analyse the effect of overweight/ obesity on patient­
perceived physical functioning and health-related quality of life one year 
after THA, taking into account the influence of comorbidity and 
perioperati ve complications. 
As already mentioned a THA can be considered as the final 
treatment modality in end-stage OA. End-stage OA is characterised by 
severe limited physical function and pain and is unresponsive to conservative 
therapy. 25 Both patients and doctors argue that a THA is supposed to 
diminish pain and increase mobility. Consequently, patients assume weight 
loss will occur naturally after their surgery, 26 while losing weight in advance 
is thwarted by physical limitations and pain. Previous research indicates this 
is not the case: patients maintain the same body weight or even seem to gain 
weight after their hip replacement. 26-30 However, so far not much is known 
about differences in effect for different subgroups of patients (normal 
weight, overweight, obese) and about the long-term effect of a THA on 
body weight. The last objective of this thesis is therefore to determine to 
what extent a THA leads to weight loss in hip OA patients categorised into 
normal weight, overweight and obese, as well as to determine the long-term 
effect of a THA on body weight. 
14 
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The present thesis 
In Chapter 2 and Chapter 3 an answer is given to the first objective of this 
thesis concerning the treatment policy of general practitioners for patients 
with OA of the hip. Chapter 2 gives an impression of the time a hip OA 
patient spends at the GP's practice and Chapter 3 provides insight into the 
GP's management before the patient is referred to an orthopaedic specialist. 
Results are compared with national and international guidelines. Chapter 4 
describes the design of a cohort study that examines the effect of a com­
bination therapy of weight loss and exercise in hip OA patients. Chapter 
5 presents the outcome of the second objective: what effect can be 
generated from a combination therapy of weight loss and exercise in hip OA 
patients, using physical function as primary outcome measure. In Chapter 6 a 
more detailed analysis of the influence of overweight/ obesity on physical 
functioning and health-related quality of life after THA is given, taking into 
account the impact of complications and comorbidities. Connecting to the 
fourth objective, Chapter 7 investigates to what extent a THA results in 
weight loss. To that end, the effect of a THA is analysed for patients with 
normal weight, overweight or obesity, and an impression is given of the 
long-term effect of a THA on weight change. Finally, Chapter 8 contains 
a general discussion of the studies presented in this thesis, with its strengths 
and limitations, and provides practical implications and recommendations 
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Abstract 
Background: Previous research on time to referral to orthopaedic surgery 
has predominantly used hip complaints as starting point instead of the 
moment the diagnosis of osteoarthritis (OA) of the hip is established, 
therefore little is known about the length of time a patient diagnosed with 
hip OA stays under the care of a general practitioner (GP) . No knowledge on 
factors of influence on this time period is available either. Aim of this study 
was thus to determine the time an incident hip OA patient stays in the care 
of a GP until referral to an orthopaedic department. Influencing factors 
were also analysed. 
Methods: A prospective observational study was conducted based on data 
over a 10-year period from a general practice-based registration network 
( 1 7 G Ps, > 30,000 patients registered yearly) . Patients with the diagnosis 
of hip OA were included. A survival analysis was used to determine 
time until referral to an orthopaedic department,and to determine 
factors of influence on this time. 
Results: Of 391 patients diagnosed with hip OA, 121 (31 %) were referred; 
average survival time until referral was 82.0 months (95% CI 76.6-87.5). 
Less contact with the GP for hip complaints before the diagnosis of hip OA 
was established resulted in a decreased time to referral. 
Conclusions: The results of this study show that patients with hip OA 
were under the care of a general practitioner, and thus in primary care, for a 




Hip osteoarthritis (OA) is a common musculoskeletal disorder. In the 
Netherlands, the number of new cases of symptomatic OA of the hip was 
found to be 1. 7 per 1000 in 2007 1 • In the US the most recent incidence 
rates were reported to be 0.9 per 1000 person-years2 • Patients with end­
stage OA often undergo a total hip arthroplasty (THA). THA is a highly 
successful treatment and the number of people indicated for this treatment 
is increasing3 •4 • 
In most European countries general practitioners are the gatekeepers 
for the medical decision-making4. Normally a patient with hip OA stays in 
the general practice until conservative treatment no longer suffices and hip 
replacement becomes an option. This is the moment the patients switches 
from primary to secondary care. 
Previous research on the management by GPs predominantly used 
hip complaints as starting point instead of the moment the diagnosis of hip 
OA was established5 •6 • Hence little is known about the length of time a hip 
OA patient generally stays under the care of a general practitioner (GP) 
from the moment the diagnosis of hip OA is established until referral to 
orthopaedics - the switch to secondary care. Insight into the length of 
time from hip OA diagnosis until referral to orthopaedics is of importance 
because it provides insight into the time available for the application and/ or 
development of non-surgical interventions. This is of major relevance as 
non-surgical interventions could significantly contribute to postponing the 
hip replacement which in turn can prevent future revision surgery. 
The literature reports variations in management of hip complaints by the 
GP5 •6 and influencing factors on these variations are suggested, like older age 
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(>60 years) and a body mass index (BMI) over 30 kg/m25 -7 • The literature 
lacks information concerning influencing factors for time to referral for 
patients diagnosed with hip OA specifically though. The aim of the present 
study was therefore to determine the time an incident hip OA patient stays 
in the care of a GP until the patient is referred to an orthopaedic department. 
The presence of influencing factors on the length of this time period was also 
analysed. 
Methods 
This was an observational cohort study. Data on morbidity and medication 
were extracted from the Dutch Registration Network Groningen. This 
general practice-based register was established in 1989, consists of three 
group practices with about seventeen GPs and is based in the north-eastern 
Netherlands. Participating GPs register all care delivered to their patients. 
About 30,000 regular patients (24,000 of them aged 18 years or older) are 
registered yearly. These patients are demonstrated to be representative of 
the national population. 
All consultations, with reasons for the visit as well as diagnoses, 
referrals and prescriptions, are registered in the RNG. Morbidity data are 
electronically recorded using the International Classification of Primary 
Care (ICPC), and each prescribed medication is provided with an ICPC­
based indication8 • This ICPC code is based on a simple biaxial structure 
consisting of a letter followed by a number. The letter represents a body 
system (e.g. L= musculoskeletal system), numbers 1-29 provide categories 
for symptoms and complaints, and numbers 70-99 represent a 
diagnosis/ disease. The medicated prescriptions were automatically classified 
22 
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with an Anatomical Therapeutical Chemical (ATC) code developed by the 
World Health Organization9 • 
The RNG register is a validated 1 0  and structured register with 
regular meetings of participating general practices twice a year, for purposes 
of maintaining an unambiguous registration, which is an ongoing process . 
Patient selection 
Incident patients aged 1 8  or older who received a diagnosis of hip OA (ICPC 
code L89) in the period between January 1 999 and December 2007 were 
included in this study. The diagnosis of hip OA was based on the definition 
of OA in the ICPC. The ICPC defines OA of the hip as a joint disorder of at 
least 3 months duration, with no constitutional symptoms and three or more 
of the following: intermittent swelling; crepitation; stiffness or limitation of 
movement; normal ESR, rheumatoid tests , and uric acid; over 40 years of 
age8 • Patients with an incidence date preceding their entry to the gener­
al practice were excluded from this study (this phenomenon occurs when 
patients transfer to another general practice and bring along 'historical' 
data) . Patients with time registration errors were also excluded. 
Data selection 
Registration data from January 1 998 to December 2008 were used to obtain 
a follow-up period (FU) and a follow-back period (FB) of at least one year 
for all study patients ( see Fig. 1 ) .  The start of the FU period was set at 
incidence date and the end at occurrence of the event 'first referral to 
orthopaedics ' ,  further addressed as 'referral ' .  If the event did not take place 
the end date was set at either the date of censoring or the end of the study 
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period (31-12-2008) . A patient was censored when leaving the general 
practice or in case of death. 
The start of the FB period was set at arrival in the general practice 
or at the beginning of the study period (01-01-1998) . The end was set at the 
last day prior to the patient's incidence date. GP consultations for hip OA 
(ICPC code L89) in the FU period and hip complaints (ICPC code L13) in 
the FB period were recorded. These contacts were classified as telephone 
contact, consultation, house call or medication prescription . Considering 
that the amount of registered contact or prescriptions is affected by the 
exposure time during FU or FB, this amount was divided by that specific 
patient's exposure years (person-years) . All GPs were visited to verify exact 
dates of hip replacements from the electronic surgical reports. 
Age at incidence date, sex, different GP practices, number of 
contact moments during FB, and number of comorbidities and amount of 
pain medication during FB were assessed as possible influencing factors. 
Comorbidities were defined as medical conditions such as overweight, 
obesity, diabetes mellitus, hip fracture, knee osteoarthritis, and cardiac, 
pulmonary, haematological, renal and oncological diseases. Pain medication 
was any medication generally prescribed for musculoskeletal pain: 
prostaglandin synthetase inhibitors, non-steroidal anti-inflammatory drugs 




Figure 1 . Timeline of incident cases 
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The data used in this study were not publicly available. The patients gave 
permission for use of their medical data if anonymised. The general 
practitioners gave permission to provide this anonymised data to the 
researcher. These GP permissions forms (in Dutch) are available upon 
request . Finally, the data acquisition was done in accordance with the 
regulations of the medical ethical board of University Medical Center 
Groningen. 
Statistical analysis 
All statistical analyses were computed using the Statistical Package for the 
Social Sciences (SPSS, Inc., Version 16.0, 2007, Chicago). Survival was 
described with Kaplan-Meier survival analyses, which were used to analyse 
time to referral and the influence of several factors on these survival times. 
A probability value of less than 0.05 is considered as statistically significant. 
Results 
The study group consisted of 391 patients; 72% was female, average age at 
the incidence date was 66. 8 years (SD 14. 0) and average exposure in the 
general practice during the FB period was 4 .8  person-years (SD 2.8) . 




Table 1 .  Baseline characteristics of study group hip OA patients* 
Variables 
Demographics 
Age at incidence date, years 
Female, % 
Clinical factors 
Exposure during FB, years 




2 >  
Number of comorbidities during FB, % 
< 2  
2-4 
> 4  
* Values are the mean (SD) unless otherwise indicated. 
OA: osteoarthritis; FB: follow-back. 
Hip OA patients (n = 391) 
66.8  (14.0) 
71 .1 







Of  all patients (N=391 ), the average survival time a hip OA patient spent in 
general practice until referral was 82.0  months (95% CI: 76.6-87 .5) (see 
Fig. 2) . After a period of 12 months, 90 patients were referred (24%) for 
the first time, after 36 months 110 patients (37%) . 
The analysis for factors of influence on survival time showed that 0 
to 0 .2 GP contact times per year for hip complaints in the FB period 
significantly decreased the survival time to 78 .2  months (95% CI 71 .8-
84 .6) .  Age, sex, number of comorbidities, amount of pain medication and 
different GP practices did not influence time to referral (p= 0.925, 






































This study showed that incident hip OA patients stayed on average 7 years 
(82 months) under the care of a general practitioner until their referral to 
orthopaedics. Of all patients in this study, 24% were referred 12 months 
after hip OA diagnosis and 37% after 36 months. The clinical consequence 
of this result is the conclusion that a considerable period of time is available 
to apply non-surgical interventions before surgery is suggested as an option . 
This is important, as non-surgical interventions could significantly 
contribute to postponing hip replacement, which in turn can delay or 
prevent future revision surgery. Future research should therefore explore 
whether and to what extent non-surgical interventions are applied during 
this time under the care of a general practitioner. 
A previously published American study 1 1  reported 1 7 .  6% referrals 
to orthopaedics in 20 months. However, that study made a distinction 
between orthopaedic referrals for evaluation, joint injection or arthroscopy 
and orthopaedic referrals for actual surgery. Only the latter category was 
considered as a "referral" for the study's outcome. This difference could 
explain the lesser number of referrals compared with the present study. 
Contrary to earlier research on influencing factors on management 
of hip complaints, this study showed just one influencing factor on the time 
until referral to orthopaedics in hip OA: a low frequency of contact for hip 
complaints with the GP before the diagnosis of hip OA is set accelerates the 
moment after the GP refers to orthopaedics. In our opinion, the only 
plausible explanation for this factor is that in patients who postpone GP 
contact the longest, the OA is so severe and advanced that the GP decides 
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not to delay any further and refers to orthopaedics. However, this cannot be 
confirmed with our data. 
Information about influencing factors on time at the GP practice for 
patients diagnosed as having hip OA, as presented in this study, is practically 
never reported in previous studies. Only the previously mentioned 
American study 1 1  examined predictors of time to referral to orthopaedic 
surgery for consideration of joint replacement, and reported that 
recruitment site was a predictor for time to referral. A possible explanation 
postulated by the authors for this finding is possible differences in regional 
waiting lists between the two analyzed groups. In the present study no 
difference was found in time to referral for the different GP practices. In 
line with the assumption of this American study, the present finding could 
be explained by referrals to various orthopaedic departments with separate 
waiting lists. The present study also presented sex as a non-influencing 
factor, which was in accordance with the American study 1 1 • 
Strengths and limitations 
The present study showed the period of time an incident patient with hip 
OA currently stays in general practice. To our knowledge, no recent study 
has reported this information before. It was a strength to have had access to 
an elaborate prospective database of a medical registration network such as 
the RN G, enabling us to gather information for an 11-year period spanning 
from January 1998 to December 2008. In this 11-year period the GPs were 
not informed about this specific data extraction and there were no limits on 
their treatment decisions (no fee-for-service). In addition it was a strength 
that the number of incident patients in the study group and the referral 
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behaviour of the RNG GPs were comparable with national figures: 
incidence figures of hip OA determined in Dutch GP practices in 2007
1 
were 1 . 7 per 1000 in one year ( versus 1 . 6 per 1000 in one year in this 
study). In 2008 GP referral to orthopaedics according to the Netherlands 
Institute for Health Services Research was 16. 4 per 1000 registered male 
patients and 21. 3 for the registered female patient 1 2 • In the same year the 
referral behaviour of the RN G network was 16. 5 per 1000 patients. A 
limitation of the study was that only access to information of registered care 
was gathered, but none about severity of the hip complaints, and no 
additional investigations were included such as X-rays of the affected hip, as 
these could have provided more information about the differences between 
patients at the moment the diagnosis was established. 
Conclusions 
Average time to referral was 82 months, i.e. 6.8 years. This indicates that a 
considerable period of time after the diagnosis is set is spent under the care 
of a GP, and thus in primary care. The importance of this knowledge can be 
translated into the assumption that general practice can operate as an 
optimal setting for the application and/ or development of new promising 
conservative interventions. 
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Abstract 
Background: In Europe, most patients with hip osteoarthritis (OA) 
receive their initial medical care from the general practitioner (GP). The 
aim of this study was to examine the frequency and nature of GP medical 
care of hip OA patients, and to determine if this care meets national and 
international guidelines for the treatment of hip OA. 
0 bj ective: To examine the frequency and nature of G Ps medical care 
of hip OA patients, and to determine if this care meets (inter)national 
guidelines. 
Method: A prospective observational study was executed. The data 
collection was carried out on anonymised records from a general prac­
tice-based research register. Patients aged 18 years and older who were 
diagnosed with hip OA in the period between January 1999 and Decem­
ber 2007 were selected for this study. GP contact data was gathered 1 year 
before and 1 year after diagnosis (total follow-up (TFU)) . 
Results: A total of 391 incident hip OA cases were identified. During the 
TFU the GP intervened in almost half of the patients. About a third 
had no contact with the GP at all. Of the 192 patients who received an 
intervention, 26% had a referral to orthopaedics . In 9 .9% of cases the 
guidelines were pursued. 
Conclusion: This study showed that the medical care of the GP can 
be defined mainly as expectant. Initial interventions consisted of pain 
medication or referral to orthopaedics. Combined interventions as proposed 




Hip osteoarthritis (OA) is a major cause of pain and disability. As a result, it 
is associated with poor health status i ,2 . OA is the most common diagnosis 
for total hip replacement surgery. In 2007, OA of the hip affected 
approximately 7% of the population aged 65 years and older in the 
Netherlands 3•4 • Due to an aging society, an increase of 25% for hip OA is 
estimated by 2050 of people aged 65 years and older in the Netherlands, 5 
which will give rise to a higher prevalence of hip OA 6 • 
In the Netherlands the initial medical care of hip OA is given by a 
general practitioner (GP) . The medical care provided by GPs is based on 
clinical guidelines when available. Dutch guidelines for osteoarthritis were 
composed by orthopaedic surgeons in 20077 (hip or knee) and by GPs in 
20088 (knee) . International guidelines are established by ACR9 (hip or 
knee, 2002), EULAR 1 0 (hip, 2005) and OARSl 1 1  (hip or knee, 2008). These 
guidelines describe conservative treatment (pharmacological and non­
pharmacological), as a single treatment or in combinations, and surgical 
treatment. Pharmacological treatment usually involves pain medication. As 
non-pharmacological treatment, exercise, aids (cane, insoles) and weight 
reduction are advised. 
Hip replacement is described as surgical treatment and although 
technical developments have prolonged the survival of a prosthesis to 10 
years 1 2 , a prosthesis deteriorates over time and subsequently may require 
revision surgery. However this procedure has an increased risk of surgical 
complications and worse outcome. A potential benefit of conservative 
treatments is postponing hip replacement and consequently revision surgery. 
Therefore proper conservative treatment by the GP is of eminent importance. 
To our knowledge, a prospective study about the application of 
medical care by GPs solely for hip OA has not been published before. 
The question thus arose of which medical care is currently conducted by 
GPs for hip OA, and whether this medical care meets the actual 
guidelines. Consequently, the main objective of this study was to 
describe the determinants, nature and frequency of GP medical 
care, and to establish whether this care meets national and 
international guidelines for treatment of hip OA. 
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Methods 
Design and setting 
A prospective observational cohort study. To select patients with hip OA, 
data on morbidity and medication from the Dutch Registration Network 
Groningen (RNG) 1 3  were extracted. This general practice-based register in 
the northeast of the Nether lands was established in 1989, and consists of three 
group practices with about seventeen GPs. About 30,000 regular patients 
( of which 24,000 are aged 18 and older) are registered yearly. Participating 
GPs register all care delivered to their patients. Consultations, with reasons 
for the encounter as well as diagnosis and prescriptions, are collected in the 
RN G. Morbidity data are electronically recorded using the International 
Classification of Primary Care (ICPC), and each prescribed medication is 
provided with an ICPC-based indication 1 4 • This ICPC code is based on a 
simple biaxial structure consisting of a letter followed by a number. The letter 
represents a body system ( e.g. L= musculoskeletal system), numbers 1-29 
provide categories for symptoms and complaints, and numbers 70-99 rep­
resent a diagnosis/ disease. The medication prescriptions were automatically 
classified with an Anatomical Therapeutical Chemical (ATC) code developed 
by the World Health Organization 1 5 • 
The RNG is a validated 16 and structured register with regular 
meetings, twice a year, of participating general practices in order to maintain 
an unambiguous registration, which is an ongoing process. 
Patient selection 
Patients aged 18 years and older who received a diagnosis of hip OA (ICPC 
code L89), irrespective of radiographic conformation, in the period from 1 
January 1999 to 31 December 2007 were included in this study. The diagnosis 
of hip OA was based on the clinical definition of OA in the ICPC, developed 
by the World Organisation of Family Doctors 1 4 • In the ICPC OA of the hip 
is defined as : joint disorder of at least 3 months duration, with no constitu­
tional symptoms and three or more of the following: intermittent swelling; 
crepitation; stiffness or limitation of movement; normal ESR, rheumatoid 
tests, and uric acid; over 40 years of age 1 4 • 
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Following patient selection, all GPs were visited to retrieve these patients' 
available orthopaedic surgery information. Exclusion criteria included 
patients who received the diagnosis of hip OA from a previous GP not 
connected to the three group practices of the RNG (this leads to 'historical' 
data). Patients with time registration errors were also excluded. 
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Determination ef the timeline 
After establishing the moment of hip OA diagnosis, a follow-back (FB) and 
a follow-up (FU) period were set, creating together the total follow-up 
period (TFU). Reason for including a FB period is that the GP can start a hip 
OA-related intervention while the diagnosis is not yet ascertained. 
To determine the length of FB and FU all the data was assembled and 
examined. This resulted in an accumulation of data within one year before and 
one year after the moment the hip OA diagnosis was made. Expansion of this 
period to two years resulted in only 1 % more data in the FB and 2 to 4% more 
data in the FU, therefore the start of the FB and the finish of the FU periods 
were fixed at one year before and one year after diagnosis ( see Figure 1). 
If a patient received a hip replacement in the FU, this FU period ended 
at that moment, resulting in a shorter FU period. There was a shortened FB or 
FU if a patient entered a GP practice during the FB period or left a GP prac­
tice (moving, death, etc.) during the FU period. Average FB and FU exposure 
times were therefore expressed in person-days. 
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period of observation 
I 
1 year pt x 
moment of hip OA diagnosis 
follow back (FB) follow up (FU) 
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Medical care consumption 
Frequency of medical care for hip complaints (ICPC code L13) in the 
FB period and hip OA (ICPC code L89) in the FU period was counted. 
Medical care was defined as all contacts with the GP or GP practice except 
for contacts related to prescription renewal. These contacts were categorized 
as 1) no intervention, 2) a conservative intervention like prescription of pain 
medication, referral to exercise therapies (physical therapy, Cesar therapy, 
rehabilitation), referral to a dietician, or 3) a possible surgical intervention 
like referral to orthopaedics. Pain medication was defined as all medication 
generally prescribed for musculoskeletal pain like prostaglandin synthetase 
inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen 
and opiates. The associated ATC group used in this study for this pain 
medication is M0l (anti-inflammatory steroids and anti-rheumatic drugs 
like rofecoxib or diclofenac) or N02 (analgesics like tramadol or codeine). A 
separate analysis was conducted per period for the TFU, FB and FU periods. 
Data analysis 
Microsoft Access 2003 was used to organize and select data from the RNG 
database. All calculations were made using the statistical package SPSS for 
Windows (SPSS Inc., version 16.0, 2007, Chicago). Patient characteristics 
were described in means and standard deviations or percentages 
distribution depending on the continuous or categorical nature of the 
variables. The number and distribution of different kinds of interventions 
were presented as frequency and percentages for the FB, FU and TFU times. 
Subsequently, the nature of the conservative interventions applied to the hip 
OA patients were calculated and presented as frequency and percentages 
for the FB, FU and TFU times, in accordance with proposed national and 
international guidelines. 
To analyse the link between frequency of contact and patient variables 
(gender and age), a regression analysis was performed using General Linear 
Models. Variation in follow-up time (exposure) was taken into account by 
specifying an offset-term for each individual observation as the natural 
logarithm of the person-days. The parameters, estimated with a Poisson 
distribution while taking into account the offset-term, represent the natural 
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logarithms of the ratio between the rate of the studied categories and the rate 
of the reference category (rate ratio) .  
Results are presented as rate ratios , obtained after taking the 
exponent of the parameter estimates and their corresponding 95% Wald 
confidence intervals. Reference categories are gender, female, and age > = 
70 . 
Results 
Patient retrieval from the RNG database resulted in 403 hip OA patients. 
Twelve patients were excluded because of registration errors. The character­
istics of the remaining 39 1  patients are shown in Table 1 .  
Table 1 .  Characteristics and clinical features of patients group N= 3.9 1  
Mean (SD) N (%) 
Age at hip OA diagnosis 66 . 8  ( 14 .0) 
Categories 




Exposure FB (person-days) 
Exposure FU (person-days) 
Female 
Male 
< 2  
2-4 
> 4  
Surgical intervention ( during the FU) 
*number of comorbidities , 
3 5 3 . 1 ( 5 7 .  7) 
3 2 2 .4 (92 .9) 
FB=follow-back, FU=follow-up , OA = osteoarthritis 
202 (5 1 .  7) 
1 89 (48 . 3) 
278 (7 1 . 1 )  
1 1 3 (28 . 9) 
227 (58 . 1 )  
1 1 4 (29 . 2) 
50 ( 1 2 . 8) 
78 ( 1 9 .9) 
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By using rate ratio's, in which exposure was expressed in natural logarithms, 
negative log function outcomes had to be excluded from the analysis. One 
person had a FB period of O days which resulted in a negative log function and 
was therefore excluded from analyses of the FB and the TFU. 
Number ef interventions 
In the total follow-up period (TFU) the GP intervened in almost half of all pa­
tients one or more times with pain medication or a referral. About one-third 
of the patients had no contact with the GP at all. In 19.2% of cases the patient 
did have contact with the GP but received no intervention (see Table 2). 
In the FB the majority of patients had no contact with the GP, in the 
FU this was a lesser number of patients. The number of patients in the FU who 
did have GP contact but no intervention was quite similar to the number of 




Table 2. Frequency of patients with or without GP interventions 1 year before and 1 year 
after hip OA diagnosis . 
No GP contact 
GP contact without intervention 
GP contact with 1 intervention 
(pain medication or referral) 
GP contact with 2 interventions 
(pain medication and/ or referrals) 
FB # (%) 
3 3 5  (85 . 9) 
26  (6 . 7) 
29  (7 .4) 
0 (0) 
FU# (%) TFU # (%) 
5 2  ( 1 3 . 3) 1 24 (3 1 . 7) 
1 59 (40 . 7) 75 ( 1 9 . 2) 
1 48 (37 . 9) 1 38 (3 5 . 3) 
32  (8 . 2) 45 ( 1 1 . 5) 
GP contact with 3 or more interventions 0 (0) 0 (0) 9 (2 . 3) 
(pain medication and/ or referrals) 
Total patients 390 ( 1 00) 39 1 ( 1 00) 3 9 1  ( 1 00) 
# = frequency, % = percentage , FB = follow-back, FU = follow-up, TFU = total follow-up, 
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Exploration ef interventions 
Of all patients, 192 had one or more interventions during the TFU period. 
In the majority of cases pain medication was prescribed or patients were re­
ferred to an orthopaedic surgeon, either way without any other intervention. 
The combination of pain medication and physical therapy or the combination 
of physical therapy and a diet, as possible part of a total management, was ap­
plied in 9. 9% of the cases ( see Table 3). 
In the FB period pain medication prescription was the main interven­
tion, followed by referral to an orthopaedic surgeon. Pain medication was 
also the most applied intervention in the FU. Physical therapy was prescribed 
less often, and the combination of pain medication prescription and physical 
therapy even less ( see Table 3) . 
Patient characteristics associated with the amount ef contact during FB, FU and TFU 
In the TFU period the older patients (2:'. 70 years) had significantly more 
contact moments than the younger patients (CI 0.75-0.99). In the FB period 
the outcome parameters elicited no significant differences in frequency. When 
exploring the FU women were more likely to have had GP contact for their 
hip OA after being diagnosed (Cl 0.69-1.00) compared to male patients. 
No significant differences in frequency were found for gender and age in the 




Table 3 .  Frequency of patients with GP interventions in hip OA patients 1 year before and 1 
year after diagnosis . 






Pain medication and Physical therapy** 
Physical therapy and Diet** 
Other - not further defined 
Total patients with interventions 
FB # (%) 
9 (28) 






32  (99) 
FU # (%) TFU # (%) 
38 (2 1 )  50 (26) 
59  (33) 6 1  (3 2) 
25  ( 1 4) 24 ( 1 3) 
0 (0) 0 (0) 
1 8  ( 1 0) 1 7  (9) 
1 ( 1 )  1 ( 1 )  
3 9  (22) 39 (20) 
1 80 ( 1 0 1 )  1 92 ( 1 0 1 )  
* This intervention occurred alone , not as a part of a management with more interventions 
** This combination can occur alone , or as a part of a management with more interventions 
� 
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Discussion 
GPs' medical care of hip OA patients predominantly showed an expectant 
management and limited agreement with national and international 
guidelines. 
In the TFU period about one-third of patients had no contact with 
the GP at all. This was mainly the case before the diagnosis of hip OA was 
made (86%) versus 13% after diagnosis. The majority of interventions took 
place in the FU period. When exploring the nature of the interventions that 
were applied, these consisted mainly of prescription of pain medication or just 
referral to an orthopaedic surgeon. Only a small number of patients received 
a conservative intervention consisting of exercise in combination with diet, or 
exercise in combination with pain medication as proposed in the guidelines. 
The current study showed a considerable number of patients who 
did not have GP contact at all, which has been discussed before in the 
literature 1 7• 1 8 • A possible reason for a patient not consulting the GP is 
suggested to be related to non-severity of the problem and consultations other 
than a GP (like a chiropractor or osteopath) 1 7 • In the situation that a patient 
did have contact with the GP but left the practice with no intervention, we 
suggest it is not unlikely that the GP discussed the options of medical care or 
lifestyle changes. 
Our finding that a large proportion of patients received pain 
medication as an initial intervention is in agreement with the 2008 study 
of Lee et al. 1 9 who analyzed the medical management of osteoarthritis in 
general . Besides the large number of patients who received pain medication 
as a first intervention, a considerably number of patients in our study was 
referred to orthopaedics without any other intervention . This latter result has 
not been previously reported. 
The outcomes in the present study regarding exercise and weight 
loss interventions show a disagreement with the existing guidelines for 
hip OA9- 1 1 • This non-agreement is in line with the study of Bierma et al . ,  
where management inconsistency was described in relation to guidelines for 
musculoskeletal problems20 • They analyzed the management of hip complaints 
among GPs in the Netherlands in 2000. However, in the comparison with the 
48 
Chapter 3 
present study it has to be taken into consideration that the patient population 
of Bierma et al . consisted of patients with hip complaints, not hip OA. 
More recently, in 2006 a retrospective study from Canada also 
concluded there was no unanimity in prescribing conservative non­
pharmacological treatments, like exercise, which are advocated in the guidelines 
for hip OA2 1 • This Canadian study involved patients with hip OA about to 
undergo total hip arthroplasty, who were questioned about the preceding 
management of their hip OA. In this article it is suggested that this dearth 
of exercise treatments is possibly related to unawareness of the benefits or 
lack of necessary skills or time regarding exercise prescription. Considering 
exercise prescription as a start for a lifestyle change, another study postulates 
that G Ps often face many barriers in offering lifestyle advice to patients2 2 •23 • 
This could also be the case in the Netherlands and therefore be an explanation 
for the presented results . 
Considering weight loss as one of the proposed non-pharmacological 
conservative treatments, the current study shows a lack of implementation 
of this treatment modality. It can be postulated that the GP had referred to a 
dietician before in relation to another medical problem. 
The finding that women with OA visit physicians more often and in 
general seek more treatment for their hip OA complaints compared with male 
patients is in line with previous research24•25 that proposes several explanations 
for gender differences, like different pain experiences or biomechanical 
diff erences25 • 
In the present study older patients showed more GP contact 
than the younger patients in the total study period. This outcome 
cannot be supported by previous research for hip OA. Help-seeking 
behaviour in people with chronic knee pain was previously analyzed 18•26 but 
nonetheless no association with age was demonstrated. 
Stren9ths and weaknesses 
To our knowledge, this study is the first to describe the nature and 
frequency of the medical care of hip OA patients in GP practices. Another 
major strength is the prospective design in which the medical care decisions 
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of the GPs were not influenced. Additionally this study reported data of a 
large study group of 391 incident hip OA patients collected in a time frame 
of 10 years. Finally, it was a strength that the number of these incident 
patients in the study group was comparable with the incidence figures of hip OA 
determined in Dutch GP practices in 2 00727, 1 . 6 per 1000 and 1 . 7 per 1000 
in one year respectively. 
Weak point of this study was the 1 year follow-up, given the 
obviously chronic nature of OA. The medical care for such a disease can be 
stretched out over several years. However, adding a year did not result in 
much more additional information in this current study. 
No further information on GP-patient communication was available, 
leaving unanswered questions about patient perspectives on the experienced 
pain and medical instructions or lifestyle advice given by the GP. 
Future research 
More research would be useful to establish the link between availability of 
hip OA guidelines for the GP and referrals to an orthopaedic department. 
Registering a high BMI as a medical problem in the GP records can be of great 
value in the assessment of medical care delivered in this patient population. 
Conclusion 
This study shows that the nature of medical care provided by GPs can be 
mainly defined as expectant. It also shows that within a time frame of one 
year before diagnosis and one year after diagnosis the nature of medical care 
consists mainly of pain medication prescription before diagnosis and pain 
medication prescription or referral to orthopaedics after diagnosis. For hip 
OA, the applied medical care is often not conform medical guidelines. 
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Abstract 
Background: Hip osteoarthritis (OA) is recognised as a substantial source 
of disability, with pain and loss of function as principal symptoms. An aging 
society and a growing number of overweight people, which is considered a 
risk factor for OA, contribute to the growing number of cases of hip OA. In 
knee OA patients, exercise as a single treatment is proven to be very effective 
towards counteracting pain and physical functionality, but the combination of 
weight loss and exercise is demonstrated to be even more effective. Exercise 
as a treatment for hip OA patients is also effective, however evidence is 
lacking for the combination of weight loss and exercise. Consequently, the 
aim of this study is to get a first impression of the potential effectiveness of 
exercise and weight loss in overweight patients suffering from hip OA. 
Methods/Design: This is a prospective cohort study. Patients aged 
25 or older, overweight (BMI > 25) or obese (BMI > 30), with clinical and 
radiographic evidence of OA of the hip and able to attend exercise sessions will 
be included. The intervention is an 8-month exercise and weight-loss lifestyle 
program. Main goal is to increase aerobic capacity, lose weight and stimulate 
a low-calorie and active lifestyle. Primary outcome is self-reported physical 
functioning. Secondary outcomes include pain, stiffness, health-related 
quality of life and habitual activity level. Weight loss in kilograms and 
percentage of fat-free mass will also be measured. 
Discussion: The results of this study will give a first impression of 
potential effectiveness of exercise and weight loss as a combination program 
for patients with OA of the hip. Once this program is proven to be effective it 




Osteoarthritis (OA) is the most common joint disorder in the world 1 • OA 
is recognized as a substantial source of disability with significant social and 
financial costs due to surgical and medical interventions and frequent 
absenteeism from work. OA of the lower limb is primarily concentrated in 
the hip and knee joint. Pain is the principal symptom of OA. At first it occurs 
after use of the joint, and is relieved by rest. In later stages of OA, pain may be 
present during rest and even sleep. Other symptoms of OA include stiffness 
following rest and instability of the joint2• 3 • 
Most recent numbers from the US ( 1990) show incident rates of OA 
of the hip of 0.5 per 1000 per year4 . In the Netherlands the incidence in 2000 
was 1.25 per 1000 per year5, and its prevalence will increase with the aging 
of Western society6 •7 • In Europe, the percentage of people over 65 years was 
17% in the year 2004. Although at 14% the Netherlands is still below this 
percentage, it is expected to increase to 24% by the year 20508 • For this 
reason, the number of people with OA of the hip in the Netherlands is ex­
pected to increase by 1.8 to 4.3% in the period 2004-20246 • A similar trend 
is seen worldwide9 • 1 0 •  
An additional risk factor for OA is being overweight or obese 1 1 • Being 
overweight is defined as having a Body Mass index (BMI) of 25-30 kg/m2, and 
being obese as having a BMI of 30 kg/m2 or more. An increase of overweight 
or obese people is seen not only in America 1 2 but in Europe as well 1 3• 1 5 • In 
the Netherlands in 2007, 45.5% of adults were overweight or obese 1 6 • 
Results from the 2003-2004 National Health and Nutrition Examination 
Survey (NHANES) indicate that 66% of American adults are either 
overweight or obese 1 7 • In this respect, not only the number of older people 
contributes to the increase of patients with hip OA, but the number of 
overweight or obese people as well. 
To date, conservative treatment modalities for OA of the lower 
limb have focused on pain relief and preservation of joint function 7• 1 8 • In these 
modalities, modification of lifestyle factors such as physical inactivity and 
overweight/ obesity is considered a core element7· 1 9 • With respect to the 
treatment of OA of the knee, it has been proven that modification of physi­
cal inactivity and obesity is an effective conservative treatment modality. 
Weight loss as a single therapy reduces symptoms of OA of the knee20•2 1 , and 
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therapeutic exercise induces the same effect7 . Combining these two 
treatments shows even more effect on pain and functionality in knee OA 22 • 
However, with respect to the treatment of OA of the hip this evidence is 
lacking. Previously conducted studies have focussed mainly on knee OA, 
or the combination of knee and hip OA, without distinguishing by joint23 • 
One Cochrane review, which did distinguish by joint, found that exercise 
treatments designed to reduce pain and improve functioning were effective 
in knee OA patients, but the same conclusion could not be drawn for hip OA 
patients due to insufficient data24 • 
The aim of this prospective cohort study is thus to get a first glimpse of 
the potential effectiveness of a combination program of exercise and weight 
loss on overweight and obese patients suffering from hip OA. 
Methods/ design 
Study design 
A prospective cohort study will be conducted at the department of 
orthopaedics of University Medical Center Groningen (UMCG) in 
collaboration with the Allied Health Care Center for Rheumatology 
Rehabilitation (AHCRR) Hilberdink. The study design, procedures and in­
formed consent are approved by the Medical Ethics Committee of UMCG. 
Identification and recruitment ef study participants 
Patients aged 25 or older, with clinical and radiographic evidence of OA of 
the hip who are also overweight (BMI > 25) or obese (BMI > 30) will be 
included. A BMI of 40 will be used as the upper limit . The clinical evidence 
of hip OA is based on the definition determined by Altman et al . 25 : a) hip 
internal rotation � 15 °, pain with internal rotation of the hip, morning 
stiffness of the hip for � 60 minutes, or b) hip internal rotation < 15 ° and hip 
flexion of � 115 °, which has a sensitivity of 86% and a specificity of 7 5%. The 
radiographic diagnosis for OA of the hip will be established by means of the 
Kellgren and Lawrence criteria26 , of which grade 1-3 will be included. 
Exclusion will be based on conditions which prevent safe 
participation in an exercise program ( angina pectoris, peripheral vascular 
disease, stroke, congestive heart failure, chronic obstructive pulmonary 
58 
Chapter 4 
disease, insulin-dependent diabetes ,  psychiatric disease, renal disease, liver 
disease, active cancer other than skin cancer and anaemia) ; problems of 
the foot or ankle that could interfere with an exercise program; rheumatic 
arthritis ; an inability to walk without a cane or other assistive device; 
participation in another research study; inability to finish the study or unlikely 
to be compliant with the opinion of the clinical staff because of frailty or 
illness; inability to fill in a questionnaire as a result of language problems or 
dementia. The assessment to include or exclude will be determined by the 
orthopaedic specialist or the general practitioner. 
Recruitment will originate from three sources : 1 )  the outpatient OA 
clinic of the Orthopaedic Department of UMCG or the Orthopaedic Depart­
ment of Martini Hospital Groningen; 2) general practices in the local area of 
the AHCRR and at the Department of General Practice of UMCG;  and 3) pa­
tients who present themselves directly at the AHCRR and meet the inclusion 
criteria, as established by their general practitioner (see figure 1 ) .  Patients 
with hip OA who meet the inclusion criteria and are not yet indicated for hip 
replacement are invited to participate . 
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The intervention is an 8-month exercise and weight-loss combination 
program under the supervision of physiotherapists and a dietician at the 
AHCRR, and will be presented to the patient as a lifestyle program. 
The exercise portion consists of an individual 3-month part and 
a 5-month group session part. The individual part consists of defining and 
improving the physical load potential of the patient, reducing current 
disabilities like lack of joint mobility and stability, optimising quality of 
movement, improving illness perceptions and enhancing physical fitness. The 
group part is focused on teaching self-management and coping, stimulating an 
active lifestyle, finding an optimal balance between exertion and relaxation, 
increasing aerobic capacity and physical fitness, increasing muscle strength, 
and decreasing limitations of activities of daily living. Aerobic capacity and 
physical fitness improvement will be achieved with the help of various devices 
like treadmills, free weight benches, stationary exercise bikes, steppers and/ 
or rowing machines. All exercises will focus on personal needs, and personal 
preferences for aerobic equipment will be taken into consideration. A weekly 
exercise session lasts approximately 1 hour. In addition, patients are urged 
to achieve a minimum of 30 minutes of moderately intense physical activity 
on most, preferably all days of the week, in order to comply with national/ 
international physical activity guidelines21·29 • At the beginning of every 
exercise session patients are asked for their activities of last week. 
Parallel to the individual and group phase of the exercise program, 
the weight-loss program is implemented by a certified dietician. This diet part 
of the intervention is based on principles of social cognitive theory, which 
argues for the important role of cognitive control systems in the acquisition of 
behavioural proficiencies30 • The weight loss program is divided into three 
phases: an intensive, a transition and a maintenance phase in concordance with 
Messier et al 22 • The main goal of the first phase is to heighten awareness of the 
importance of and need for changing eating habits. In this phase the ability to 
read and understand the diversity of labels in food products will be enhanced, 
and the patient will set goals he believes he can achieve. In the transition 
phase, problems the patient encounters will be discussed and self-insight will 
be enhanced concerning the choices that can be made when buying food. 
Goal in this phase is to prevent relapse. Finally, in the maintenance phase the 
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main objective is to maintain the achieved weight loss and to preserve the 
motivation to keep on going with the healthy eating habits. Adherence to the 
intervention is based on attendance at scheduled sessions. 
In addition to the combination program ( exercise and weight loss), 
patients receive a manual consisting of written information that focuses on 
health education, including topics about the medical background of OA, OA 
treatments, and coping with chronic pain. 
Sample size 
Considering the calculation of the sample size, the study of Messier22 is used 
as a reference. In this study Messier showed that a combination of exercise 
and weight reduction in patients with OA of the knee led to a significant 
improvement (a < 0.05) on the primary outcome measure of self-reported 
physical function. In order to find an analogous improvement of self-reported 
physical function of approximately 25% between the first (TO) and last meas­
urements (T2) in patients with OA of the hip, a minimum of 20 patients is 
needed. This number is based on a power ( 1-B) of 0. 80 and a significance level 
of 5% (two-sided). When a dropout rate of 20% is taken into account, at least 
25 participants have to be included. 
Outcome measurements 
At baseline (TO), information is gathered about the patients' demographics 
( educational level, marital status, family composition) and comorbidities as 
well as about medication and supplemental use. 
Primary outcome measurement 
The Western Ontario and McMaster Universities Osteoarthritis Index (WOM­
AC) :  self-reported physical functioning is the primary outcome measure, 
to be measured with the physical function subscale of the Dutch version 
of the WOMAC (Dutch-WOMAC)31•32 • The WOMAC Index is a disease­
specific measure of health status and is widely used and recommended in 
OA research. The validity, reliability and responsiveness of this measure have 
been demonstrated in an extensive range of studies33 • The Dutch version of 
the WOMAC has also been considered valid, reliable and reproducible32 • 
The Dutch WOMAC consists of three dimensions: pain (5 items), stiffness 
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(2 items) and physical functioning (17 items). Responses on the 24 items are 
given on a 5-point Likert scale. All scores will be recoded into a 100-point 
scale, indicating a score of O as the worst possible health condition and 100 the 
best possible health score. 
Secondary Outcome measurements 
To add information about the potential effectiveness of the intervention, 
participants will be assessed using a range of standardised, self-report 
measures that include: 
1. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) : the 
other two dimensions of the Dutch WOMAC, pain and stiffness. 
2. Short Form Health Survey (SF-36) :  the SF-36 measures health-related quality 
of life and is considered to be valid, reliable and reproducible34 • The SF-36 
is composed of 36 questions, organised into 8 multi-items scales: physical 
functioning, role limitations due to physical health problems, bodily pain, 
general health perceptions, vitality, social functioning, role limitations due to 
emotional problems and general mental health34 • 
3 .  Short Q.!!estionnaire to ASsess Health enhancing physical activity (SQYASH) : 
The SQUASH is designed to give an indication of habitual activity level. 
The SQUASH consists of 6 main questions and is subdivided in 4 categories: 
(A) commuting activities, (B) leisure-time activities, (C) household activities, 
and (D) activities at work and school. With the help of the Ainsworth 
compendium of physical activities35 , the SQUASH subdivides activities into 
three intensity categories for adults and for older adults (up to age 55 and 
older). These intensity categories are determined by MET values. MET stands 
for metabolic equivalent and is defined as 'the ratio of the work metabolic rate 
to the resting metabolic rate' . For adults, intensity of activities with a MET­
value between 2 and < 4 was classified as light, between 4 and < 6 .5 as mod­
erate, and � 6.5 as vigorous. For older adults, intensity of activities between 
2 and < 3 MET was classified as light, between 3 and < 5 MET as moderate, 
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Activities with a MET-value lower than 2 will not be analysed because they are 
considered to contribute negligibly to habitual activity level. The SQUASH 
is structured in such a way that it is also possible to assess compliance with 
physical activity guidelines. The SQUASH is proven to be a fairly reliable 
and reasonably valid questionnaire36 • The measurement properties of the 
SQUASH have been assessed in a population of adults, where it showed an 
overall reproducibility of 0.58 (95%-CI 0.36-0.74). The relative validity in 
this study was 0.45 (95%-CI 0.17-0.66) 36 • In a population of overweight 
people3 7 and of people after total hip arthroplasty38 , the Squash was 
validated with use of an accelerometer with a correlation of 0.40 (p = 0.05) 
and 0.67 (p = 0.01) respectively. Furthermore, Spearman's correlation 
coefficient for overall reliability in the overweight study was not applicable, 
but the hip arthroplasty study showed a value of 0.57 (95%-CI 0. 35-0. 73)38 . 
Patients will also be evaluated using objective measurements, which include: 
1. 6-Minute Walk Test (6MWT) . The 6MWT is a functional walking test 
developed to measure functional status39 . The test provides information about 
gait speed and functional and endurance capacity. The primary outcome is the 
total distance walked. The 6MWT is considered a reliable test 40•41 • 
2. 20-MeterWalk Test (20MWT) . The 20MWT is a short, safe test used to meas­
ure gait speed like the 10MWT42 •43 • Patients walk indoors on a 20-m long 
track, and the time spent to complete the walk (in seconds) will be measured. 
Time recording will be accomplished with electronic timing equipment by 
means of photocell gates (HL 2-31 Photocell, Tagheuer, la Chaux-de-Fond, 
Switzerland). 
3. Weight and Jatjree mass assessment.  The amount of lost weight and the amount 
of fat-free mass can give an indication of improvement of the overweight 
problem. Weight will be measured with a calibrated scale, always performed 
by the same dietician. The fat-free mass measurement will be assessed by a 
hand-held impedance analyser (Omron Body Fat Monitor, model BF 306). It 
is concluded that the Omron BF 306 body fat monitor yielded results close to 
the D EXA Body Fat% 44 • 
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4. Compliance with the program. Compliance will be registered by AHCRR 
diet and exercise session attendance. This attendance will be assessed by 
dividing number of exercise sessions participants actually attended by the 
number of sessions participants were asked to attend, multiplied by 100%. 
The first measurement will take place before the combination program 
begins (TO). The second measurement (T 1) will take place at the beginning of 
the exercise group portion of the combination program after 3 months, and 
the third measurement (T2) at the end of the combination program after 8 
months (see figure 2). 
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Figure 2. Study design and assessment points 
Study population (n = 25) 





Final 8 -month (T2) 
Questionnaire 
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- SF- 36 
- Squash 
- 6MWT & 20MWT 
- Weight / Fat-free % 
- Compliance 





Final 8-month (T2) 
Objective measurements 
- 6MWT & 20MWT 
- Weight / Fat-free % 
- Compliance 
TO = start of the intervention program, Tl = 3 months , T2 = 8 months, end of the program 
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Statistical analysis 
All statistical analyses will be computed using the Statistical Package for 
the Social Sciences (SPSS, Inc., Version 16.0, 2007, Chicago) . Descriptive 
statistics will be used to describe the group. Changes in response outcomes 
from measurement points TO to T2 will be assessed with the GLM AN OVA 
repeated measurements analyses. Changes in outcomes between 
measurement pointsT0 andT2 (pre- and post-measurement) will be analysed 
with a paired samplesT-test. For all test procedures, a probability value of less 
than 0.05 will be considered as statistically significant. 
Time frame 
This study has an 18-month time frame. It is anticipated that identification of 
potential study participants and recruitment will commence in January 2009. 
Data analysis will be performed in February 2010 and the final report will be 
drafted afterwards. 
Discussion 
The objective of this prospective cohort study is to get a first glimpse of the 
potential effectiveness of exercise and weight loss on overweight patients 
suffering from hip OA. If this study indeed demonstrates that the proposed 
combination program seems to be effective for hip osteoarthritis, it will 
be followed by a randomised controlled trial (RCT). In this RCT the 
effectiveness of the combination program will be investigated in a more 
controlled setting and will also include a closer look at the cost effectiveness 
of the combination program. Potential effectiveness of the combination 
program implies benefits for patients as well as society. 
Patient benefits 
A potential benefit for the patient is that the moment of joint replacement can 
be postponed. Although technical developments have prolonged the lifecycle 
of hip prostheses, a prosthesis tends to be replaced after a mean of 10 
years45 ( what is known as a revision). Revision surgery has greater risks than 
primary surgery, such as an increased chance of septic loosening. Especially in 
the case of young people, this is an important reason to postpone a total joint 
replacement . Conservative therapy (e.g. exercise in combination with weight 
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loss) can therefore be a valuable tool towards accomplishing this46 , and al­
though scientific evidence is lacking, structured exercise and weight loss are 
already recommended in the clinical setting as a conservative treatment op­
tion for patients with OA of the hip47 • 
Secondly, regular physical activity can have a positive effect on 
the general health and fitness of the patient . There is a known dose-response 
relation between physical activity and health, and according to the 
recommendations of the ACSM is it important to promote physical activity 
in older adults that emphasises moderate-intensity aerobic activity and 
muscle-strengthening activity27•29 • Regular physical activity has been 
consistently and reliably linked to a reduction in all-cause mortality, 
cardiovascular disease and many other debilitating conditions29 • In addition 
to the beneficial effects of physical activity on health, regular physical 
activity also increases older adults' ability to perform their daily activities, 
thus enhancing their quality of life48 • 
In case of weight loss, health benefits are observed in patients with OA 
in the form of reduced self-reported disability20 and improved self-reported 
physical function20•22 • Published reviews in the obesity literature indicate that 
obesity impairs health-related quality of life (HRQL) and that higher degrees 
of obesity are associated with greater impairment49 • Rejeski48 pursued this 
subject in patients with OA, demonstrating that lifestyle modifications like 
dietary and physical activity behaviours are important interventions for 
enhancing HRQ L 48 • Additionally, weight loss has induced positive 
improvements in sexual quality of life dimensions50 , which can also be 
considered as important in the overall rating of quality of life. 
Social benefits 
In light of the forecasts of a sharp accumulation of patients with OA, the 
potential effectiveness of the proposed combination program provides 
substantial social benefits. This conservative program, considered as lifestyle 
management, can assist in the approach towards dealing with the large 
number of people with hip osteoarthritis and most probably reduce the 
medical costs these patients incur, like physician appointments, medication, 
outpatient clinical visits and physiotherapy. Eventually, research into the 
combination of exercise and weight loss in overweight and obese patients 
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suffering from hip OA can provide government agencies and social insurance 
organisations with evidence to incorporate this kind of therapy for hip 
osteoarthritis into medical insurance packages. The positive effects of the 
combination program could end up supporting referral to the program by 
clinicians caring for people with OA of the hip. 
In conclusion, this study will provide highly relevant data on the potential 
effect of exercise and weight reduction among people suffering from OA of 
the hip. 
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Abstract 
Background: Osteoarthritis (OA) is the most common joint disorder 
in the world and is recognized as a substantial source of disability. For OA 
of the knee, exercise in combination with weight loss is a proven effective 
conservative treatment option, yet this evidence is lacking for hip OA. 
Objective: To get a first impression of the effect on physical function of a 
combined exercise and weight-loss program in patients with hip OA who are 
overweight/ obese. 
Design: A prospective cohort study. 
Subjects and methods: Thirty-five patients aged 25 years or older, 
with clinical and radiological evidence of hip OA who were overweight/ obese 
(BMI > 25 kg/m2) were included. The patients participated in an 8-month 
exercise and weight-loss combination program. A BMI of 40 kg/m2 was used 
as upper limit. Primary outcome was self-reported physical functioning, as 
measured with a subscale of the WOMAC. Additionally, an objective measure­
ment was taken using the 6-minute walking test (6MWT) . 
Results: Participation in the combination program resulted in a clinically 
relevant improvement of self-reported physical function. In addition, 
significant improvement was seen in walking ability as an objective measure 
of physical function. 
Conclusions: To our knowledge, this is the first study to investigate 
the effect of exercise and weight loss as a combination treatment in hip OA 
patients. The results indicate that the combination of exercise and weight loss 




Osteoarthritis (OA) is a chronic musculoskeletal disease that usually affects 
hands and weight-bearing joints such as knees and hips. OA is the most common 
joint disorder in the world 1 and is recognized as a substantial source 
of disability. In 2007, OA of the hip affected approximately 7% of the 
population aged 65 years and older in the Netherlands. 2•3 Due to an aging 
society, an increase of 25% for hip OA is estimated for people aged 65 years 
and older in the Netherlands by 2050,4 which will give rise to a higher 
prevalence of hip OA.5 A similar trend is seen worldwide.6•7 
In addition to an aging society, the increasing number of over­
weight or obese persons will also give rise to a higher prevalence of hip OA. 8 
Recent research strongly indicates that overweight/ obesity is a risk factor 
for hip OA.9 The number of overweight or obese persons is a serious 
problem in the world . Approximately two-thirds of the world population are 
overweight or obese, and obesity has increased in Europe and globally in the last 
decade. 10 1 4  
Most recent recommendations for the conservative treatment of hip 
OA focus on pain relief and preservation of joint function, and combinations 
of non-pharmacological and pharmacological interventions are described . 1 5- 1 9  
As a non-pharmacological intervention it is recommended that both exercise 
and weight loss play an important role in managing symptoms in patients with 
hip as well as knee OA. However, these recommendations are mostly based on 
knee research .  
There is evidence in the literature demonstrating the benefits of 
exercise for both hip and knee OA patients. Furthermore, knee OA research 
shows that combining exercise with weight loss produces more effects on 
pain and function than either of them alone. 20•2 1  For weight loss and the 
combination of exercise and weight loss, the recommendation for hip OA is 
primarily based on knee OA research because of the limited availability of 
evidence on patients with hip OA. The main problem is that in the existing 
studies where an intervention effect for both knee and hip OA were 
analysed, the outcomes were not distinguished by joint. 22 Hence for hip OA 
the evidence for a combined treatment of weight loss and exercise is lacking, 
whereas it is plausible this combination treatment would have a positive effect 
in hip OA too. 
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The objective of this study was therefore to get a first impression of the effect 
on pain and physical function of a combined exercise and weight loss program 
in patients with hip OA who are overweight/ obese. 
Methods/Design 
Study desi9n 
A prospective cohort study was conducted at the Department of 
Orthopaedic Surgery of University Medical Center Groningen (UMCG) 
in collaboration with the Allied Health Care Center for Rheumatology and 
Rehabilitation (AHCRR) Hilberdink and Vive Diet and Lifestyle Consultancy, 
both situated in Groningen, the Netherlands. The study was designed to 
analyze the effect of a combination program of exercise and weight loss on 
overweight and obese patients with hip OA. 
The study was approved by the Medical Ethics Committee of UMCG. A de­
tailed description of the design of the cohort study is published elsewhere. 23 
Trial Registration number is NTR1053. 
Identification and recruitment ef study participants 
Patients aged 25 years or older with clinical and radiological evidence of hip 
OA24•25 who were overweight or obese (BMI > 25 kg/m2) were included. 
A BMI of 40 kg/m2 was used as upper limit . Exclusion was further based 
on conditions which prevented safe participation in an exercise program. 
Patients who were on waiting lists for hip replacement at enrolment were 
also excluded. Eligibility was determined by the orthopaedic surgeon or the 
general practitioner, depending on the recruitment source. 
The recruitment originated from five sources: 1) the outpatient OA 
clinics of the Orthopaedic Department of UMCG and Martini Hospital Gro­
ningen; 2) general practitioners in the local area of the AHCRR and at the 
Department of General Practice of the UMCG; 3) patients who presented 
themselves directly at the AHCRR and met the inclusion criteria as estab­
lished by their general practitioner; 4) local paper advertising; and 5) website 
advertising of UMCG. 
Eligible patients who came through sources 1 to 3 were identified 
through medical specialists and the researcher asked for permission to contact 
them. If written consent was given the initial questionnaire was mailed to the 
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patient and an initial appointment was scheduled. Patients who responded 
through sources 4 or 5 were first seen at the outpatient OA clinic of the 
Department of Orthopaedic Surgery of UMCG, where the orthopaedic 
surgeon determined if the patient was eligible for the study. 
Intervention 
The intervention was an 8-month exercise and weight-loss combination 
program, and was introduced to the patient as a lifestyle program. The 
program was supervised by physiotherapists and a dietician. The exercise 
portion consisted of an individual and a group session part lasting 3 and 5 
months respectively. The individual part consisted of defining and improving 
the physical load potential of the patient, such as improving muscle strength 
and practicing activities in which limitations are established, reducing 
current disabilities like lack of joint mobility and stability, optimizing quality 
of movement, improving illness perceptions, and enhancing physical 
fitness. The group part focused on teaching self-management and coping, 
stimulating an active lifestyle, finding an optimal balance between exertion 
and relaxation, increasing aerobic capacity and physical fitness, increasing 
muscle strength, and decreasing limitations of activities of daily living. Aerobic 
capacity and physical fitness improvement were achieved with the help of 
various devices like treadmills, free-weight benches, stationary bikes, 
steppers and rowing machines. All exercises focused on personal needs, and 
personal preferences for aerobic equipment were taken into consideration. 
The weekly sessions lasted approximately 1 hour. 
The diet portion was based on principles of social cognitive theory26 
and was divided into three phases: an intensive, a transition and a maintenance 
phase in concordance with Messier. 21 The main goal of the first phase was 
to heighten awareness of the importance of and the need to change eating 
habits. In this phase the ability to read and understand the diversity of labels 
in food products was encouraged, and the patient set goals he believed he 
could achieve. In the transition phase, problems the patient encountered were 
discussed and self-insight was stimulated concerning the choices that could 
be made when buying food in order to prevent relapse. Finally, in the main­
tenance phase the main objective was to sustain the achieved weight loss and 
preserve the motivation to keep on going with the healthy eating habits. 
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In addition to the combination program of exercise and weight loss, 
patients received a manual consisting of written information that focused 
on health education and OA. During the whole program the focus lay on 
teaching self-management and stimulating an active lifestyle combined 
with healthy eating. Adherence to the combination program was based on 
attendance of scheduled sessions and utilization of the possibilities to catch up 
with any missed session. 
Outcome measurements 
At baseline (TO), information was gathered about patients' demographics 
( educational level, marital status, family composition) and comorbidities as 
well as about pain medication and glucosamine use. 
Primary outcome measurement 
Self-reported physical functioning as primary outcome measure was 
measured with a subscale of the Dutch version of the Western Ontario 
and McMaster Universities Osteoarthritis Index (Dutch-WOMAC).27•28 
The WOMAC Index is a disease-specific measure of health status and is 
widely used and recommended in OA research . All scores were recoded 
into a 100-point scale, with a score of 0 indicating the worst possible health 
condition and 100 the best possible health score. 
Secondary outcome measurements 
Additional measurements were conducted and divided into subjective (e.g. 
questionnaires) and objective measurements. 
Questionnaires 
By means of two subscales of the Dutch-WOMAC, information was gathered 
on stiffness and pain. An impression of health-related quality of life was 
acquired by means of the Short Form 36 item (SF-36) general health 
questionnaire, 29 using the subscales of physical functioning, role-physical, 
bodily pain, and general health. In addition, pain was also measured with a 
10-point VAS score (average hip pain experience in the previous period) . 30 
All VAS scores were recoded, indicating a score of 0 as "the worst possible pain" 
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and 10 as "no pain". Physical activity behavior was measured with the Short 
QUestionnaire to ASsess Health enhancing physical activity (SQUASH)3 1 . 
The SQUASH questionnaire is well-known and frequently used in the 
Netherlands to measure physical activity behavior. 32-35 Outcome was activity 
score in minutes per week, measured in three intensity categories based on 
MET values. 
All questionnaires used are reliable and valid for the use in the Dutch 
situation and were completed at home. By doing this, possible unintended 
influences on the results caused by an unblinded researcher were prevented. 
Walking tests 
The measurement of functional status and gait speed consisted of the 6-
Minute Walking Test (6MWT)36 and the 20-Meter Walking Test (20MWT). 
The 20 MWT is a short, safe test used to measure gait speed comparable to 
the 10 MWT. 37•38 Patients walk indoors on a 20-m-long track, and the time 
spent to complete the walk (in seconds) is measured. Time recording was 
accomplished with electronic timing equipment using photocell gates (HL 
2-31 Photocell, Tagheuer, la Chaux-de-Fond, Switzerland) . 
Weight and fat-free mass 
Weight was measured in kg with the help of a calibrated scale, fat-free 
measurement by a handheld impedance analyzer Omron Body Fat Monitor 
(model BF 306) . 39 
Compliance 
The adherence of the patient to the program was registered. Attendance was 
assessed by dividing the number of exercise sessions participants actually 
attended by the number of sessions participants were asked to attend, 
multiplied by 100%. 
The first measurements ( questionnaires, walking tests, body fat and weight 
measurement) took place before the combination program started (TO). 
The second measurement (T 1) took place at the beginning of the exercise 
group portion of the combination program after 3 months ( questionnaires, 
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weight measurement), and the third measurement (T2) at the end of the 
combination program after 8 months ( questionnaires, walking tests, body fat 
and weight measurement). 
Sample size 
A priori, the sample size calculation was based on the primary outcome 
measure of self-reported physical function as determined with the Dutch­
WOMAC. To determine the magnitude of a minimal difference the study 
of Messier was used as a reference, in which a combination of exercise 
and weight reduction in patients with OA of the knee led to a significant 
improvement (a < 0.05) on the primary outcome measure of self-reported 
physical function. In order to detect a similar improvement in self-reported 
physical function of approximately 25% between the first (TO) and last 
measurements (T2) in patients with OA of the hip, a minimum of 20 patients 
was needed. This number is based on a power ( 1 -B) of 0.80 and a significance 
level of 5% (two-sided) . When a dropout rate of 20% was taken into account, 
at least 25 participants were to be included. 
Statistical analysis 
The data were analyzed using the Statistical Package for the Social Sciences 
(PASW statistics 18.03.2010, New York). Descriptive statistics were used 
to describe the main characteristics of the group. Generalized estimating 
equations (GEEs) were used to investigate the time-course of all 
measurements in the patients. The GEE adjusts for the correlation between 
repeated observations taken from the same subject and is able to handle 
longitudinal data on subjects with a varying number of unequally spaced 
observations. In all analyses, an exchangeable correlation structure was 
assumed. For all test procedures, a probability value of less than 0.05 was 
considered as statistically significant. For effect modification analysis, the 
variables of age and gender were taken into account and a significance level of 




The total number of patients recruited through five different sources and 
eligible for the study was 35. Patients who were lost to follow-up during the 
program (n= 5) suffered from too much pain (n= 1 ), major depression (n= 1 ), 
an ankle fracture (n= 1 ), or an inability to reach the physiotherapy institute 
every week ( n = 2). These patients did not differ at baseline from those who 
completed the final measurements on age or BMI. The amount of body fat was 
lower in those patients who were lost to follow-up ( 41 % versus 31 % ) . The 
patient group therefore consisted of 30 patients, of which 57% were women 
and 67% were obese ( see Table 1). 
Table 1 .  Characteristics of overweight or obese hip OA patients (n=30) 
Age in years, mean ± SD 56 .9  ± 1 1 . 9 
Women, n (%) 1 7  (56 . 7) 
Education, n (%) 
Therapy length in months, mean ± SD 
Use of pain medication*, n (%) 
Use of glucosamine, n (%) 
Low 14 (46 .7) 
Middle 8 (26.  7) 
High 8 (26.  7) 
8 . 3  ± 1 . 6 
Yes 1 0  ( 3 3 .  3) 
No 14 (46 . 7) 
Unknown 6 (20.0) 
Yes 10 ( 3 3 .  3) 
No 1 9  (63 . 3) 
Unknown 1 (3 . 3) 
BMI in kg/m2 , mean ± SD 32 ± 3 .9 
Body fat %, mean ± SD 41 ± 6 .4  
* prostaglandin synthetase inhibitors, nonsteroidal anti-inflammatory drugs 
(NSAIDs) , acetaminophen or opiates. 
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Primary outcome 
The primary outcome was self-reported physical function as measured 
with the subscale of the WOMAC. The GEE analysis showed that patients 
significantly improved their physical function after three and after eight 
months compared to their baseline score (see Figure 1 ) .  
Secondary outcome measurements 
Questionnaires 
There was a significant decrease in WOMAC pain, VAS pain and SF-36 pain 
after 3 months, and a more prominent decrease after 8 months compared to 
baseline (see Table 2) . The SF-36 score of physical functioning and physical role 
limitations perception also showed a significant change after 3 and 8 months 
(see Table 2) . The SF-36 score of general health perception only showed 
a significant improvement after 8 months. No change in activity scores as 
determined with the SQUASH was observed except for the vigorous-intensity 
activities, which after 3 months showed an increase of 57 minutes per week 
(95%CI 1 4.1 to 99.4 I p  <0.05) .  












Womac physical functioning 
* 
■TO CT1 CT2 
Presented are group mean with standard error (SE). Number of observations: 90. 
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Table 2. GEE regression results for the change in time 
Variable Baseline Time Regression coefficient 
score (months) (95 % CI) 
Subjective results 
WOMAC 59 .8  Base o· 
pain Post I 9 .9 (4.6 to I S . I )* 
Post 2 1 5.2 (9.4 to 2 1 .0)* 
WOMAC 49.6  Base o· 
stiffness Post I I 1 . 3 (5 .7  to 1 6. 8)* 
Post 2 1 6 .8  ( 1 2 . 3  to 2 1 .4)*  
VAS 3 .7  Base o· 
pain Post 1 2 . 5  ( 1 .7  to 3.3)* 
Post 2 3 . 1  (2 . 3  to 4.0)* 
SF-36 45 .6 Base o· 
Physical Post 1 1 2 . 5  (7.7 to 1 7.4)* 
functioning Post 2 2 1 .5  ( 1 4.8  to 28 . 1 )* 
SF-36 35 .8  Base o· 
Role-Physical Post 1 24.7 (9 .7 to 39.7)* 
Post 2 36 .8  ( 1 7 . 8  to 55.9)* 
SF-36 52.5 Base o· 
Bodily Pain Post 1 1 1 . 1  ( 5 .7 to 1 6.6)* 
Post 2 1 9.2  ( 1 0.0 to 28 .4)* 
SF-36 6 1 .9 Base o· 
General Health Post 1 5 .4 (-0.9 to 1 1 . 7) 
Post 2 9.4 (3 .4 to 1 5 . 3)* 
SQ-activity score 2037 .5  Base o· 
(min/week) Post 1 2 1 2 .4 (-4 .8 to 429.6) 
Post 2 -35.6 (-289.6 to 2 1 8 .5)  
SQ-light activity 1 473 .2  Base O" 
score Post 1 1 04.8 (-50.9 to 260.6) 
(min/week) Post 2 -8 .7 (-250. 3 to 232 . 8) 
SQ- moderate 392 . 2  Base o·· 
activity score Post 1 50.8 (- 1 1 6.5 to 2 1 8 . 2) 
(min/week) Post 2 -68 . 2  (-226.0 to 89.  7) 
SQ- vigorous 1 72.2 Base o· 
activity score Post 1 56 .8 ( 1 4. 1 to 99.4)* 
(min/week Post 2 4 1 .3 (-6 . 2  to 88 .9) 
Objective results 
Walking test 433 . 3  Base o· 
6 minutes (meters) Post 2 48 . 1  (26.7 to 69.4)* 
Walking test 1 5 . 3  Base o· 
20 meter (seconds) Post 2 - 1 . 2 (- 1 .8 to -0.6)* 
Body weight (kg) 95.0 Base o· 
Post 1 - 2 . 8  (-4.4 to - 1 . 2)* 
Post 2 - 5 . 6  (-7.7 to -3.4) 
Body fat (%) 41 .0 Base o· 
Post 2 - 3 . 3  (-4.6 to -2. 1 )* 
• Set to zero (baseline score used as reference). * significant change = p<.05 . 
GEE, generalized estimating equations. Base = baseline, Post 1 = after 3 months, 
Post 2 = after 8 months. 
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Walking tests 
Both walking tests (6MWT and 20MWT) showed a significant improvement 
after 8 months (Table 2 ) .  
Weight and fat-free mass 
After 3 months and also after 8 months there was a significant decrease in 
body mass of respectively 2 . 8  kg (95% CI: -4 .4  to - 1 . 2  / p <0 .05)  and 5 . 6  
kg (95%CI : -7 .7  to - 3 .4 / p < 0 . 00 1 )  compared to baseline (Table 2) . Body 
fat was 4 1 . 0% at baseline and showed a significant reduction of - 3 .  3 % in 8 
months (95%CI -4 . 6  to -2 . 1  I p=0.000) . 
Confounding and Effect modification 
No confounding for any of the outcome measurements was found. 
Additionally, the GEE analysis showed no effect modification by gender and 
age at baseline for the change of physical function or pain score in time ( data 
not shown) . 
Compliance 
There was an adherence of 94% for both the individual- and the group­
exercise portion. For the diet portion, adherence was 82%.  Catch-up sessions 
were possible in both parts of the combination program ( exercise and diet) . 
Discussion 
The results of this study show an improvement of self-reported physical 
function in patients with hip OA who were overweight or obese after 
8 months when following an exercise and weight loss program. The 
combination program resulted in an improvement in self-reported 
physical function. An improvement was also seen in objective measurements 
(e .g. walking abilities) . Moreover, the increase of physical function can be con­
sidered clinically relevant, as a minimal improvement of 1 2% of the WOMAC 
score compared to baseline is suggested as a clinical relevant one . 40 
To our knowledge, the effect of exercise and weight loss as a combina­
tion program has not been studied before in hip OA patients. A comparison can 
therefore only be made with those studies that examined the effect of exercise 
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and weight loss in knee OA patients , and with studies that examined the 
effect of only exercise in hip OA patients. First of all , in comparing the 
present study to other studies that implemented exercise and weight loss as a 
combination therapy in knee OA patients , there were only slight differences 
in the outcomes , such as the outcome of the self-reported physical function of 
the WOMAC. Messier et al . 2 1 used this outcome in their combination therapy 
study for knee OA patients , showing an improvement of 24% compared to 
baseline after the 6-month combination intervention . Our study resulted in a 
slightly greater improvement of 32% compared with baseline after 8 months 
of exercise and weight loss. The main differences between the study of Messier 
et al . and the present study were the mean age of the patient group, which was 
1 2  years lower in our study, and the execution of the exercise intervention. In 
Messier's study the patients had to exercise 3 days/week at the facility for at 
least 4 months, after which they could choose for a home-based program or 
continuing at the facility. In our study the patients presented themselves once 
a week at the facility and additionally exercised at home during the entire 
program (8 months) . Both differences could explain the slightly better results 
of our study. 
The significant improvement of 1 1 . 1  % on the 6-minute walking 
distance in our study was comparable with the study of Messier, who found 
an improvement of 1 5 . 9% after 6 months . In the present study, patients also 
had a decrease in self-reported WOMAC pain score of 25 .4% after 8 months, 
which is comparable with the decrease of 24. 8% after 6 months observed 
by Messier et al . Rejeski et al . ,  41 after studying obese knee OA patients who 
underwent a combination intervention of exercise and weight loss, showed 
a decrease of pain of 1 2 . 2  points in the SF-36 bodily pain subscale after 1 8  
months compared with the baseline score. In our study the outcomes were 
obtained after 8 months and showed more improvement compared with 
Rejeski ( 1 9 . 2  points of the SF-36 bodily pain score) . The different mean age 
at baseline may have contributed to a difference in pain outcome compared 
to our study (age 69 in Rejeski's study versus 57 in ours) . Also, in our study 
patients were already included if they were overweight, which means a BMI 
of 25 kg/m2 and higher (resulting in a lower mean BMI of 32 kg/m2) ,  instead 
of an inclusion criterion of a BMI of 28 kg/m2 and higher like in the study 
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of Rejeski et al. (which resulted in a mean BMI of 34 kg/m2). As weight has 
a high-loading impact on the joint,42 which contributes to the extent of pain 
symptoms, this can be an explanatory factor. 
For self-reported physical function measured with the SF-36, 
Rejeski found a baseline improvement of 8. 5 points after 18 months. This 
improvement was comparatively rather low, as our study showed a 21.5-point 
improvement after 8 months. The amount of weight loss in our study was 
comparable to the study of Rejeski and Messier, that around 5%. Our 
additionally measured loss of body fat (3.3%) had not been analysed before 
in the literature, but gives a strong indication for an effective combination 
program involving calorie burning, which was aimed for in our study. 
Now comparing the results of the present study to other studies that 
implemented solely exercise therapy in hip OA patients, it can be concluded 
they are in line with and slightly support the combination therapy of the 
present study. An example is the study of J uhakoski et al., 43 which used the 
self-reported physical function score of the WOMAC. In this study exercise 
was administered in 12 sessions once a week at the facility, subsequently 
followed by home-based exercises. Compared to baseline, patients 
demonstrated an increase of 15. 7% after 6 months on self-reported physical 
function. This is a lower increase compared to our study (32%), which 
probably can be explained by the shorter exercise program of Juhakoski 
(3 months versus 8 months in our study). The significant improvement of 
1 1 .1 % of the 6-minute walking distance in our study was considerably higher 
compared to Juhakoski's, which showed an improvement of only 5% after 
3 and 4% after 12 months. Additionally, in the present study patients had a 
decrease in the self-reported WOMAC pain score of 25 .4% after 8 months; 
Juhakoski found a smaller decrease of 7 .1 % after 6 months. 
Another study, by Tak et al., 44 examined the effect of exercise in 
hip OA patients. Their observed decrease of pain measured with the VAS 
pain score was only 7%. The VAS pain score in the present study decreased 
considerably more 84% compared with the baseline score. The baseline 
pain score in our study was however much worse ( 3. 7 compared with 6. 2 in 
Tak's study), therefore a regression to the mean effect in our study could be 
possible. Apart from the difference in content of the intervention ( exercise 
versus exercise and weight loss), the difference between Tak's study and ours 
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is primarily based on the intervention length, theirs being substantially short­
er at 8 weeks ( 1  session per week) . Additionally, the mean age in their study 
group was higher ( 1 0  years) . All those differences in study methods could 
have had an influence on the differences found in outcomes. 
Despite the overall promising effect of the combination program, no 
significant change in self-reported activity could be demonstrated in our study. 
While our compliance score showed a good average compliance, it could be 
assumed that patients had at least one additional active encounter per week 
compared to baseline. A possible explanation for not demonstrating a change 
in activities could be the large standard deviations within this relatively small 
patient group, of whom it is known that activity scores are prone to large 
individual differences. 
Strenaths and limitations 
To our knowledge, the present study is the first one published regarding 
exercise and weight loss as a combination treatment for hip OA patients . 
It takes a step forward in the research of conservative treatment aimed at 
hip OA patients exclusively. Additionally, our patient group originated from 
diverse sources, which gives a good generalizability to the average OA patient 
who has not had hip arthroplasty yet . 
As the objective of the study was to get a first impression of the 
effect of exercise and weight loss as a combination treatment, it was decided to 
conduct a cohort study. This can be considered a limitation, as a study design 
with a control group is methodological stronger. Another consequence of this 
decision is that our patient group size was relatively small . The power of the 
study was not endangered though, presenting a study group of 30 patients , 
while our sample size calculation instructed inclusion of at least 25  
participants. 
Future research 
Further research in a controlled setting is needed to determine the effect 
of exercise and weight loss as a combination in hip OA patients , and to 
determine if the effect can be maintained beyond 8 months and can 
subsequently postpone hip surgery as well . 
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Conclusion 
Overall it can be concluded that the intervention of the present study 
generates the same beneficial effects for patients with hip OA compared with 
combination interventions of exercise and weight loss in patients with knee 
OA. It can also be concluded that the present intervention for hip OA patients 
shows more improvements in symptoms when exercise is accompanied by 
weight loss, compared with exercise-only interventions. Nevertheless, we are 
aware of the challenges of comparing differently executed programs in terms 
of type of exercises, mode of delivery and contact moments, which are all 
known to have their own effect on outcome.20 
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Abstract 
Background: Overweight/ obesity in patients after total hip arthroplasty 
(THA) is a growing problem and is associated with postoperative 
complications and a negative effect on functional outcome. Objective of this 
study is to determine to what extent overweight/ obesity is associated with 
physical functioning and health-related quality of life one year after primary 
THA. 
Methods: A retrospective analysis of prospectively collected data from 
65 3 patients who had undergone a primary THA was conducted. Physical 
functioning, health-related quality of life, body mass index (BMI), 
comorbidity and postoperative complications were assessed by means of 
a questionnaire and from medical records. To determine to what extent 
overweight/ obesity is associated with physical functioning and health-related 
quality of life after THA, a structural equation model (SEM) analysis was 
conducted. 
Results: The association of BMI corrected for age, gender, complications 
and comorbidity with physical functioning is -0.63. This means that an 
increase in 1 kg/m2 BMI leads to a reduction of 0.63 points in the 
physical functioning score as measured with the Western Ontario and 
McMaster Universities Osteoarthritis Index (100-point scale) . The prevalence 
of complications or comorbidity leads to a reduction of respectively 5.63 and 
7.25 (one or two comorbidities), and 14.50 points in the case of more than 
two comorbidities on the physical functioning score. The same pattern is 
observed for health-related quality of life. 
Conclusions: The influence of overweight/ obesity on physical 
functioning and health-related quality of life is low. The impact of 
complications and comorbidity is considerable. Refusing a patient a 




Osteoarthritis (OA) of the hip is one of the most prevalent age-related 
musculoskeletal conditions, leading to a significant impairment in patients' 
ability to perform activities of daily living and having a large impact on health­
related quality of life1• 2 • In the US population, symptomatic OA of the hip is 
reported to affect 8. 7% of men and 9. 3% of women aged 45 years or older3 • 
Among the Dutch population these prevalences were 2. 5 % for men and 5. 0% 
for women in 20004 . Total hip arthroplasty (THA) is a highly successful and 
widely applied treatment for advanced OA of the hip, with 202,500 primary 
THAs performed in the US in 2003 5 and 20,266 in the Netherlands in 20086 • 
In the year 2006, an estimated 40% of adults aged over 65 in the US 
general population were overweight, and another 22% were obese7 • In the 
Dutch general population, almost 57% of adults over age 65 were overweight 
in 2006, while 14% were obese8 • Overweight is also a growing problem 
in patients after a THA. Overweight/ obesity is associated with a negative 
effect on functional outcome afterTHA and on implant longevity. It can affect 
polyethylene wear negatively. Studies have also found a correlation between 
obesity and higher infection rates and risk of dislocation, aseptic loosening 
and revision9- 1 2 • Moreover, with respect to general health, overweight/ obesity 
is considered a risk factor for hypertension, diabetes type 2, coronary heart 
disease, stroke, gallbladder disease, respiratory problems and some forms 
of cancer (National Institutes of Health) 13 • The World Health Organization 
(WHO) considers obesity as a chronic disease 14 • 
Limited research has been conducted so far into the potentially 
negative effect of overweight/ obesity on functional outcome 
and health-related quality of life after THA9 • Based on the 
scarce research done it is difficult to draw uniform conclusions, 
as different instruments, points in time and perspectives (physician­
based vs. patient-based) have been used 1 5-22 • Moreover, for research 
conducted into the effect of overweight/ obesity on functional outcome and 
health-related quality of life after THA, one must ask whether comorbidity 
and complications also have to be taken into account2 1 • As mentioned, 
overweight and obesity are associated with a variety of additional health 
problems, and the same applies for postoperative complications. 
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Few studies have taken the influence of comorbidity and complications 
into account when assessing the influence of overweight/ obesity on 
patient-perceived physical functioning and health-related quality of life. 
Therefore, the aim of the current study is to analyse the effect of overweight/ 
obesity on patient-perceived physical functioning and health-related quality 
of life 1 year after THA. As overweight/ obesity is considered one of the risk 
factors for a spectrum of comorbidity and postoperative complications, 
the additional effect on physical functioning and health-related quality of 
life of comorbidity and postoperative complications in combination with 
overweight/ obesity was analysed. 
Materials and Methods 
Subjects 
A retrospective analysis was done on prospectively collected data. Data was 
collected in three orthopaedic centres' ( one university medical centre, two 
regional hospitals) in the Netherlands. All patients who had undergone an 
elective primary THA because of primary OA of the hip between February 
2005 and January 2007 were consecutively included. Patients who had died 
at the time of follow-up, who had other lower-limb arthroplasties performed 
in the period of follow-up, or who had cognitive limitations were excluded. 
Patients were sent a self-report questionnaire with an explanatory letter 1 
year postoperatively (mean, 52.4 weeks; SD, 3.9 weeks). 
Surgery was performed by 1 5  staff surgeons, or under direct 
supervision of one of these surgeons. Patients were operated using a 
posterolateral or anterolateral approach. This approach was surgeon-specific, 
with each surgeon using the same approach consistently for all THAs 
performed during the study period. Different types of implants and fixation 
types were used. Patients were allowed full weight bearing the second day 
after surgery, using crutches during the first three postoperative months. 
The study was approved and conducted in accordance with the 
regulations of the medical ethical boards of the participating hospitals. 
Patients were informed in the explanatory letter that return of the completed 




To measure patient-perceived physical functioning, the Dutch-language 
version of the Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) was used23• 24 . The WOMAC is a widely used disease-specific 
questionnaire for measuring outcome after THA 25 • Using a Likert scale, 
individuals rate themselves on multiple items grouped into three domains: 
pain (5 items), stiffness (2 items) and physical functioning (17 items) . The 
scores of the subscales make up the total score. The total score of 96 points 
is recoded into a 100-point scale, with a higher score representing better 
physical functioning. To get an impression of health-related quality of life, the 
subscale of self-perceived general health of the Short-Form 36 health survey 
(SF-36) was used26 • General comorbidity was measured with the 12-item 
list from Nilsdotter27 • Patients were rated as having no complications, one or 
two complications, or more than two. Body mass (kg) and height (m) were 
self-reported. Body mass index (BMI) was calculated by dividing body mass 
in kilograms by height in square meters. A BMI < 25 kg/m2 was considered 
a normal weight, between 25 and 30 kg/m2 overweight and > 30 kg/m2 
obese. Age, gender and complications (perioperative and postoperative) were 
extracted from the medical records. 
Statistical analysis 
Statistical analyses were performed using the SPSS 16 software (SPSS Inc, 
233 S Wacker Dr, Chicago, IL 60606, USA) and Mplus version 528 • 
Descriptive statistics were used to depict the main characteristics of the 
patients. ANOVA with Bonferroni adjustment was used to compare 
continuous variables between three BMI groups (BMI < 25 kg/m2, BMI 25-
30 kg/m2 and BMI > 30 kg/m2) . To determine to what extent overweight/ 
obesity (independent variable) is predictive of patient-perceived 
physical functioning (WOMAC total score) and self-perceived general health 
( dependent variables), linear regression analysis was used. In addition, 
comorbidity (no, one to two, >2; no comorbidity=ref.) and complications 
(yes/no; no = ref.) were included as dummy variables in the analyses to 
correct for their influence. A p-value of < 0.05 was considered statistically 
significant. 
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The linear regression analysis was performed with a structural 
equation model (SEM) technique in order to determine to what extent 
overweight/ obesity is associated with patient-perceived physical functioning 
and self-perceived general health after THA. Dependent variables were 
patient-perceived physical functioning and self-perceived general health. 
Independent variables were BMI, age, gender, complications and comorbidity. 
BMI was centered at 25 as being the upper limit of a healthy weight and age 
at 70 years (the mean age of this study population). In addition, based on the 
SEM, the correlation of the two dependent variables was calculated. 
Results 
Of the 848 eligible patients, 653 (77.0%) returned complete question­
naires and were included. There were 484 female patients (74.1 %) . Mean 
age at surgery was 70.3 years (SD, 8.2 years; Table 1). Mean BMI of the 
patients was 27.0 kg/m2 (SD, 4.1 kg/m2) .  Most of the patients lived with 
a partner ( 59 .1 % ) and had a lower educational level ( 49. 3%; Table 1). 
Table 1 . Baseline characteristics of the study population. 
Total BMI < 25 BMI 25-30 BMI > 30 
N=543-653* N = 1 9 1 -2 1 3* N=2 29-275* N = l  1 1 - 1 37* 
Mean (SD/%) Mean (SD/%) Mean (SD/%) Mean (SD/%) 
Age 70. 3  (8 . 2) 70 . 8  (8 . 8) 70. 1  (8 .0) 69 . 5  (7 .8)  
Gender (% women) 74.2% 80. 3% 68 .9% 73.0% 
Education 
Lower 322 (54.8%) 87 (40.8%) 1 47 (53 . 5%) 77 (56. 2%) 
Secondary 201 (34.2%) 88 (4 1 . 3%) 72 (26. 2%) 40 (29. 2%) 
I ligher 65 ( 1 1 . 1 %) 26 ( 1 2 . 2%) 32  ( 1 1 .6%) 6 (4.4%) 
Missing values 65 ( 1 0%) 1 2  (5 .6%) 24 (8 .7%) 14 ( 1 0. 2%) 
BMI 27.0 (4. 1 )  22 .9  ( 1 .7) 27 .2  ( 1 . 3)  33 .0  (2 .9) 
Comorbidity 
None 1 8 1  (27.7%) 50 (2 3 . 5%) 77 (28 .0%) 36 (26. 3%) 
1 -2 263 (40.3%) 98 (46 .0%) 1 1 1  (40.4%) 50 (36 .5%) 
> 2  209 (32 .0%) 65 (30. 5%) 87 (3 1 . 6%) 5 1  (37.2%) 
Missing values 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Complications 
Yes 47 (7.2%) 1 3  (6 . 1 %) 25 (9 . 1 %) 9 (6.6%) 
No 603 (92. 3%) 1 98 (93 .0%) 249 (90.5%) 1 28 (93 .4%) 
Missing values 3 (0.5%) 2 (0.9%) 1 (0.4%) 0 (0%) 
*clue to missing data the n is variable 
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A total of 181 patients (27.7%) reported no additional comorbidity, 
263 patients (40.3%) one to two comorbidities, and 209 patients (32.0%) 
more than two comorbidities. Complications occurred in 47 (7.2%) patients. 
There were eight (1.2%) dislocations, three (0.5%) sciatic nerve palsies, three 
(0.5%) superior gluteal nerve palsies, two (0.3%) periprosthetic fractures, 
and two (0.3%) malpositioned prostheses necessitating revision surgery. 
Patients did not differ with respect to mean age at surgery, 
comorbidity or complications between the three BMI categories. With 
respect to gender there were significantly more women in the BMI < 25 
group. 
In order to determine to what extent overweight/ obesity influences patient­
perceived physical functioning and self-perceived general health afterTHA, an 
SEM analysis was conducted. The model had four steps. The first step/model 
determined the association of BMI with patient-perceived physical function­
ing and self-perceived general health, while the second model determined the 
independent effect of age and gender. In the third step/model, the effect of 
BMI, age and gender were added into the model. In the final step (model 4) 
comorbidity and complications were added to estimate their additional effect 
(Table 2). 
The influence of BMI on patient-perceived physical functioning and 
self-perceived general health as depicted in model 1 (Table 2) was -0.35 
(p=0.07) and -0.59 (p=0.001 ), respectively. This means that, with every 
increase of 1 kg/m2 BMI the score on patient-perceived physical functioning as 
measured with the WOMAC (100-point scale) is reduced by 0.35 and on the 
self-perceived general health subscale of the Short-Form 36 (100-point scale) 
by 0.59 points. In model 2, the separate influence of age and gender are 
reported; in model 3, in combination with BMI. In both models, the influence 
of gender on patient-perceived physical functioning is distinct (respectively, 
-3.88 (p=0.02) and -4.53 (p=0.01 )). Finally, model 4 reports the influence 
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Table 2. Structural equation model analyses. Estimate and standard error (SE) of patient-perceived physical functioning and self-perceived general 
health (SF-36) (dependent variables) on overweight/obesity, age, gender, complications and comorbidity (independent variables). 
Model I Model 2 Model 3 Model 4 
Self-perceived Patient- Self-perceived Patient- Self-perceived Patient- Self-perceived Patient-
general health perceived general health perceived general health perceived general health perceived 
physical physical physical physical 
functioning functioning functioning Functioning 
Estimate S.E. Estimate S.E. Estimate S.E. Estimate S.E. Estimate S.E.  Estimate S.E. Estimate S.E. Estimate S.E. 
(P-value) (P-value) (P-value) (P-,·alue) (P-value) (P-value) (P-value) (P-, alue) 
Intercept 65 .59 0.89 80.98 0 .84 64.92 1 . 5 3  82 .72 1 .44 65 .9 1  1 .60 84.44 1 . 50 75 .07 1 . 83 90.92 1 .78 
BMI (centr: 25) -0. 35  0. 1 9  -0. 59 0. 1 8  -0.41  0. 1 9 -0.65 0. 1 8  -0.40 0. 1 8  -0.63 0. 1 8  
(p=0.07) (p=0.001 ) (p=0.03) (p<0 .001 ) (p=0.03) (p<0 .001 ) 
Age ( centr: 70) -0.30 0 . 1 0  -0.24 0.09 -0.3 1  0 . 1 0  -0.23 0.09 -0 .24 0.09 -0. 1 8  0.09 
(p=0.00 1 ) (p=0.0 1 ) (p=0.001 ) (p=0.01 ) (p=0.0 1 ) (p=0.04) 
Gender (ref: 0. 10  1 .78 -3.88 1 .68 -0.24 1 . 80 -4. 53  1 .70 -0.06 1 .70 -4.41 1 .65 
male) (p=0.96) (p=0.02) (p=0.90) (p=0.01 ) (p=0.97) (p=0.01 ) 
Complications -8 .  1 9  0.99 -5 .63 0.96 
(ref: no (p<0.00 1 ) (p<0.00 1 ) 
complications) 
Comorbidity -7.02 2 .82 -7 .25 2 .74 
(ref=0 = no; (p=0.01 ) (p=0.01 ) 
t = l-2; 2= >2) 






With respect to patient-perceived physical functioning, every increase in 
1 kg/m2 BMI leads to a reduction of 0.63 points on the WOMAC score 
(p=0.001). By contrast, the prevalence of complications or comorbidity 
leads to a reduction of, respectively, 5 .63 (p= <0.001) and 7 .25 (p=0.01) 
points on the WOMAC score in the case of one or two comorbidities and a 
reduction of 14.50 points on the WOMAC score in the case of more than two 
comorbidities. With respect to the self-perceived general health of the 
SF-36, the same pattern is seen, although the influence of gender is 
less prominent. The correlation between the two dependent variables, 
patient-perceived physical functioning and self-perceived general health, is 
0. 3 5 in the last model . The R 2 for these last models was 0. 10 for patient­
perceived physical functioning and 0.13 for self-perceived general health, 
which implies that 10% and 13% of the variance could be explained ( data not 
shown). 
Discussion 
It is generally considered that overweight/ obesity is associated with a 
negative effect on outcome after THA and on implant longevity. From the 
results of our study it can be concluded that the influence of overweight/ 
obesity on patient-perceived physical functioning and self-perceived general 
health is low, both without and with correction for the other co variables. The 
sole influence of 1 kg/m2 increase in BMI leads to a reduction in the score 
on patient-perceived physical functioning as measured with the WOMAC 
by 0.35 points and on self-perceived general health as determined with the 
Short-Form 36 by 0.59 points. This implies that, compared to a person with 
a BMI of 25 kg/m2, someone with a BMI of 35 kg/m2 of the same age and 
gender has a reduction in score on physical functioning and health-related 
quality of life of respectively 3. 5 and 5 .  9 points. Corrected for the influence 
of complications, comorbidity, and the demographic variables, the influence 
of BMI remains more or less the same. On the other hand, the influence 
of complications is considerable and leads to a reduction in the physical 
functioning score of 5.63 points and health-related quality of life of 8.19 
points. For comorbidity, the same pattern is seen with a reduction of 7. 25 
points for one or two comorbidities and 14.50 points for more than two 
comorbidities on the physical functioning score, and a comparable effect on 
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health-related quality of life with a reduction of, respectively, 7.02 and 14.04 
points. 
The question thus arises as to whether these effects can be considered 
clinically relevant. Angst et al. 29 report that differences larger than 6% of the 
maximum score on the WOMAC (96/ 100 points) and SF-36 ( 100 points) 
can be considered clinically relevant. With the exception of more than two 
comorbidities (reduction of 14.04 points on the SF-36 health perception 
scale), none of the variables lead to a 1 elevant effect on their own, yet the 
combination of factors can rapidly lead to relevant differences. For example, 
being a woman in combination with a BMI of 30 kg/m2 and one or two 
comorbidities already leads to a clinically relevant effect on the physical 
functioning score. Still, overall, it can be stated that the sole effect of BMI on 
physical functioning and health-related quality of life is low and will only lead 
to a clinically relevant effect in extreme situations. On the other hand, the 
effects of comorbidity and complications are substantial. 
Based on the aforementioned results it can be argued that, in future 
research, comorbidity and complications have to be taken into account, oth­
erwise an incorrect and incomplete picture is obtained. Until now, only a few 
studies have taken comorbidity and complications into account when assessing 
the influence of overweight/ obesity on physical functioning and health-related 
quality of life. The findings of our study are in line with research by Kessler 
& Kafer 1 6 , McCalden et al . 1 7 , Moran et al. 1 8 , Stickles et al. 1 9 , and Andrew et 
al. 20 • Kessler & Kafer used the WOMAC as outcome measure. They concluded 
that overweight/ obesity is of no influence, yet they measured 10 days and 3 
months postoperatively. McCalden et al . 1 7  measured after a mean period of 
8. 4 years postoperatively and concluded that morbid obesity does not affect 
the postoperative outcome after THA as measured with the WO MAC, 
SF-12, and Harris Hip Score (HHS). Moran et al. 1 8  concluded that BMI did 
not lead to clinically relevant effects on the postoperative HHS and SF-36. 
Unlike the aforementioned studies, Moran et al. took both complications and 
comorbidity into account. However, it must be mentioned that we used a 
patient-based outcome (WOMAC) and Moran et al. used a physician-based 
outcome (HHS). Additionally, Stickles et al. 19 and Andrew et al. 20 concluded 
that obese patients enjoy as much improvement and satisfaction as non-obese 
patients. Stickles et al. found that there were no significant differences 
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between obese and non-obese patients with respect to their improvement 
on the WOMAC score and the Physical Component and Mental Component 
scores of the SF-36 .  Andrew et al . concluded that there was no difference in 
the change in the Oxford Hip Score (OHS) between obese and non-obese 
patients five years postoperatively. 
It can be concluded that the results of our study are contrary to results 
reported by Busato et al . 2 1 , who measured the effect of a high BMI on 
functional outcome in a cohort of 1 8 , 968 patients. They found that a high BMI 
is associated with decreased ambulation during a follow-up period of 1 5  years. 
By contrast, we measured only 1 year postoperatively, and our good results at 
that point do not rule out deterioration later on . Comparing our results with 
those of the study of Jackson et al . 22 leads to a mixed picture : they found a 
significant difference between obese and non-obese patients in favour of the 
non-obese group with respect to the postoperative HHS. And yet, they found 
no difference between the two groups in overall satisfaction with surgery. 
Finally, it can be concluded that with the exception of the Moran 
study, none of these studies takes the additional effect of comorbidity into 
account. The substantial impact of comorbidity found in our study is in line 
with suggestions stated in research by Braeken et al . 1 5 , who argued that 
more attention should be paid in future research to the potentially negative 
influence of comorbidity on physical functioning after THA. 
Once again, a strength of our study is that not only the influence 
of overweight and obesity were taken into account but also the influence of 
additional comorbidity and postoperative complications . Additional strong 
points of our study are the size of our study group and the response rate of 
77 .0%.  In order to get an impression of the representativeness of our study 
group we determined the response rate by BMI category. As the BMI of the 
non-responders was not available 1 year after THA, we used the BMI (of both 
responders and non-responders) that was determined when the patients were 
admitted to the hospital for surgery. Divided by BMI category the response 
rate was , respectively, 76 .0% (BMI < 25 kg/m2) , 8 1 . 5% (BMI 25 - 30 kg/ 
m2) , and 7 1 . 1  % (BMI > 30 kg/m2) . From this, it can be concluded that no 
response bias was present. A weak point is that height and weight and thus 
BMI were self-reported. This probably leads to an underestimation of the 
problem, as it is known that people tend to underestimate their weight and 
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overestimate their height30 • Secondly, we used the 12-item list from 
Nilsdotter27 to get an impression of the presence of comorbidity. It can be 
argued that not all comorbidity is included in this instrument. On the other 
hand, the most prevalent comorbidities or health problems associated with 
overweight/ obesity, like heart disease, hypertension, peripheral artery 
disease, diabetes and cancer, are included in this instrument . Finally, our 
study was limited to the patients' 1-year postoperative status. The long-term 
influence of overweight/ obesity on patient-perceived physical functioning, 
health-related quality of life, and prosthetic longevity could not be 
determined. This latter point needs particular attention, as the present study 
used self-reported instruments and consequently no objective information 
was gathered about the effect of overweight on the prosthesis. 
Conclusions 
Overall it can be concluded that the influence of overweight/ obesity on 
physical functioning and health-related quality of life both with and without 
correcting for the other co variables is low. On the other hand, the impact of 
complications and comorbidity is considerable . Especially the combination of 
factors can rapidly lead to clinically relevant differences. In that sense, it can 
be concluded that future research into the effect of obesity I comorbidity on 
physical functioning and health-related quality of life must take comorbidity 
and complications into account, otherwise an incorrect and incomplete 
picture is obtained. Finally, based on the results of this study, it can be 
concluded that refusing a patient a THA solely on the basis of overweight or 
obesity seems unjustified. 
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Abstract 
Background: Elevated body weight is associated with hip osteoarthritis 
(OA) and subsequently with total hip arthroplasty (THA) . Patients with hip 
OA who are overweight often mention their restricted mobility as a factor 
that thwarts their attempts to be physically active and lose weight. There is 
some evidence that THA increases physical activity but none for losing body 
weight afterTHA. 
0 bj ective: The purpose of this study was to analyse the short- ( 1-year) and 
long-term (4 .5-year) effects of a THA on body weight. 
Design: This was an observational multicenter cohort study. 
Methods: For the short-term effect all patients (N=618) were analysed, 
for the long term a random subgroup (N= l 00). Pre- and postoperative body 
weight and height were self-reported . Patients were categorized according 
to their preoperative body mass index (BMI<25 kg/m2 = normal weight, 
25-30 kg/m2 = overweight, >30 kg/m2 = obese) . Clinical relevancy was set 
at a minimum of 5% weight loss compared with baseline. 
Results: The mean age of the study group was 70 years (SD 8), 74% 
were women, mean preoperative body mass 79 kg (SD 14). One year after 
THA a significant decrease in body weight occurred of 1 % and 3. 4% for the 
overweight and obese BMI categories respectively (p<0.00). After 4.5 years 
a significant decrease in body weight of 6.4% occurred for the obese BMI 
category (p<0.000) . 
Limitations: Height and weight - and thus BMI - were self-reported. 
Conclusion: Patients in the overweight and obese groups showed a 
decrease in body weight after 1 year, albeit not clinically relevant. After 4. 5 
years a decrease was observed that was clinically relevant in obese patients. It 
can be concluded that no clinically relevant reduction of weight occurred after 




Osteoarthritis of the hip is one of the most prevalent age-related chronic 
conditions. 1 • 2 It causes a significant impairment in patients' mobility and has 
a high impact on quality of life. 3 Total hip arthroplasty (THA) has become 
known as a highly successful treatment for advanced osteoarthritis. The 
incidence of patients with hip osteoarthritis (OA) who need a hip 
arthroplasty is growing. The yearly numbers of hip arthroplasty 
interventions in the Netherlands for 1995-2005 increased from 13,785 to 
20,715 - almost 50%. A need for 51.000 hip prostheses per year is expected 
for the year 2030. 4 One explanation for this increase is that in Western 
societies, including the Netherlands, older adults are growing in number 
as well as in age. 5 Another explanation for the increase in the need for hip 
prostheses is the growing number of patients who are overweight, 6-8 as a high 
BMI is considered a risk factor in the development of OA. 9 
Patients who are overweight and awaiting hip arthroplasty are advised 
strongly to lose body weight in advance, by increasing physical activity or 
through nutritional change. An important reason for losing weight is to 
increase the chance of surgical success by lowering infection rates and reducing 
problems of wound-tissue healing. 1 0• 1 1  However most of patients report not 
being able to lose weight because of physical limitations and pain. Because the 
hip arthroplasty is supposed to diminish pain and increase mobility, patients 
assume weight loss will occur naturally after their surgery. 1 2  
Losing weight after hip arthroplasty is no less important. A high body 
mass index (BMI) after hip arthroplasty surgery has implications for implant 
stability with a 6 fold higher risk for implant dislocation compared to patients 
with a low BMI. 1 3 • 1 4  In addition Roder et al (2008) showed that each extra 
unit of BMI increases stem-loosening odds. 1 5  Finally, it is known that a high 
BMI can also affect polyethylene wear negatively, which in turn has a negative 
effect on implant longevity. 1 6  With respect to general health, overweight or 
obesity is considered a risk factor for all kinds of serious illnesses, like diabetes 
type 2 and coronary heart disease, 17 which also advocates for losing weight 
after aTHA. 
From the small number of studies presenting change of body weight 
in patients with hip OA who were overweight, it can be concluded that these 
patients do not lose weight after hip arthroplasty; some of these studies 
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presented no change and some showed an increase in body weight. However, 
there are some points of criticism that can be raised with respect to these 
past studies, e.g. the fact that some used no BMI categories (normal weight, 
overweight or obese); 1 8• 1 9 that patients were retrieved from one source (e.g. 
university or regional hospital), which might have consequences for the 
generalizability of results; 1 2 • 1 8-2 1  that some studies did not consider the 
influence of comorbidities or presurgical fitness status (American Society of 
Anesthesiologists [ASA] status) in their analyses; 1 2 • 1 8 • 1 9•2 1  and that the effect 
was determined only 1 year afterTHA. 1 8 •20 
The objective of this study was therefore to analyse the short-term and long­
term effect of THA on body weight taking into account the aforementioned 
points of criticism. 
Methods 
Desi9n and settin9 
An observational multicenter cohort study was conducted at the University 
Medical Center in Groningen (university hospital), Martini Hospital in 
Groningen (large teaching hospital) and Ropcke-Zweers Hospital in 
Hardenberg (regional hospital) . All hospitals are situated in the northern part 
of the Netherlands. Recruitment for the study started in 2005 and the last 
data were collected in 2010. 
Ethical approval 
The study was approved and conducted in accordance with the regulations of 
the medical ethics boards of the participating hospitals. 
Data collection 
Patients' sex, age at surgery, self-reported height, self-reported body weight 
and ASA ( American Society of Anesthesiologists) status were recorded from 
medical records. The ASA status is a standard measure of fitness for surgery, 
scored in this study from 1 (normal, healthy) and 2 (mild systemic disease) 
to 3 (severe systemic disease).22 Postoperative self-reported body mass was 
obtained through questionnaires, with a mean of 1 (short-term) and 4 .5 years 
(long-term) postoperatively. These questionnaires also asked whether the 
patients had had other knee and/ or hip surgery in the follow-up period . 
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Selection criteria 
Patients admitted to the orthopaedic surgery department because of primary 
hip OA for an elective THA in 2005 and 2006 were eligible for the study 
(n=848) and invited to participate by sending a questionnaire 1 year after 
surgery (short-term effect). A total of 653 patients returned the 
questionnaire, and their medical records were assembled to collect body 
weight and height at time of surgery. A flow chart of the study population is 
presented in Figure 1 . 
To get an impression of the long-term effect, approximately 20% of the 
1-year follow-up group was selected at random. In this draw the different 
ratios related to the origin of the patients from the 3 different hospitals were 
taken into account. In addition, a non-response of 20% was taken into account 
which eventually led to 150 patients who were sent a questionnaire for the 
second time. 
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Figure I .  Flow chart of the study population 

































Included in the study 
b) returning questionnaire 
n= 653 
Lost to follow-up (n =35) 
- missing prcopcrathc data 
Analyzed short-term (1 year) 
n = 6 1 8 
! 
Assessed for subgroup 
n= 1 50 
Returned questionnaires 
n= ! 06 
Non-response (n == 44) 
- deceased (5) 
Lost to follow-up (n=6) 
- missing data 
Analyzed long-term (4.5 years) 
n = 1 00  
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Height, Body Weight and Body Mass Index (BM!) 
Preoperative height and body weight from the medical records was self­
reported, as well as the postoperative data. Preoperative BMI was calculated 
by dividing body weight in kg by height in square meters. For preoperative 
BMI, the patients were divided into BMI categories defined as normal weight 
(BMI < 25 kg/m2) , overweight (BMI between 25 and 30 kg/m2) and obese 
(BMI > 30 kg/m2) . 23 
Body weight change 
Body weight change was measured per BMI category and considered clinically 
significant if the loss or gain was at least 5% of the preoperative weight. 
24 
This minimum amount of weight loss is required to induce metabolic and 
cardiovascular health benefits. 25 
Statistical analysis 
Descriptive statistics were used to describe the study sample. The baseline 
characteristics between the study group and the subgroup were compared 
for differences using chi-square and independent t-test analyses. Generalized 
estimating equations ( G EEs) were used to investigate the time-course of body 
weight in the patients who had a THA at baseline. 26 The GEE adjusts for the 
correlation between repeated observations taken from the same individual 
and is able to handle longitudinal data on participants with a varying number 
of unequally spaced observations. An exchangeable correlation structure was 
assumed in all analyses. All statistical analyses were performed with PASW 
Statistics 18. A significance level of p<0.05 was considered statistically 
significant. For effect modification analysis the variables sex, age at surgery, 
other knee and/ or hip surgery and ASA status were taken into account and a 
significance level of p<0.01 was considered significant statistically. 
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Results 
A total of 65 3 patients returned the questionnaire (77%) 1 year after surgery. 
The response rates for the 3 hospitals were respectively 61 % (university 
hospital), 74% (large teaching hospital) and 95% (regional hospital). In 35 
medical records preoperative weight and/ or height could not be found. As 
a result, 618 patients were included in the 1-year follow-up. In the 5-year 
follow-up group 106 patients (71 %) returned the questionnaire. The response 
rate for the three hospitals was respectively 60% (university hospital), 81 % 
(large teaching hospital) and 73% (regional hospital). For 6 patients, data were 
incomplete, which led to the inclusion of 100 patients. The mean follow-up 
time of the long-term follow-up group was 4.5 years. 
Demo9raphic characteristics 
Table 1 shows the demographic characteristics and the BMI and ASA 
classification of the short-term (1 year) and long-term (4 . 5  years) follow-up 
groups at baseline. In both groups most patients were overweight and had 
mild systemic disease at the time of surgery. 
Table 1 .  Demographics (preoperatively) 
Age (yrs) 
Gender (n / % female) 
Height (m) 
Body weight (kg) 
BMI category (n / % ) 







Short-term ( 1  yr) 
follow-up group 
(n=6 1 8) 
70. 2  (8 .2)  
458 / 74. 1  
1 68 . 1  (9 . 2) 
78 .6  ( 14.0) 
1 62 I 26 .2  
294 / 47 .6  
162 I 26. 2 
1 72 I 27. 8 
398 / 64.4 
46 / 7.4 
Long-term (4.5 yr) 
follow-up group 
(n= lO0) 
70.7 (8 . 1 ) 
72 / 72 .0 
1 68 .9  (7 .6) 
8 1 . 2  ( 1 6 .4) 
24 / 24.0 
46/ 46 .0 
30/ 30.0 
3 3  I 33 . 0  
60  I 60.0  
7 / 7.0 
BMI = Body Mass Index / Values in mean (SD) unless otherwise indicated 
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The representativeness of this long-term follow-up group also was analysed. 
To that end,  the demographic characteristics and baseline BMI and ASA scores 
were compared between the short-term follow-up groups. These data were 
shown to be comparable; no statistical differences were found . 
Short-term effect ojTHA on body wei9ht 
In Figure 2 the mean (±standard error) body weight of patients is shown 
per BMI category preoperatively and 1 year postoperatively. The GEE analysis 
showed a significant increase in body weight of 0. 7 kg in the group with 
normal weight 95% confidence interval [CI] = 0. 1 to 1 .4) , which 
corresponds to a 1 . 1 % weight gain; a significant decrease in body weight 
of 0 . 8  kg (95% CI = - 1 . 2 to -0 . 3) in the group with overweight, which 
corresponds to a 1 .0% weight loss ; and a significant decrease in body 
weight of 3 . 2  kg (95% CI = -4 . 2  to -2 . 2) in the group with obesity, which 
corresponds to a 3 .4% weight loss. The GEE analysis showed no 
confounding or effect modification by gender, other knee and/ or hip surgery, 
or age at surgery for the change of body weight in time (data not shown) . 
Figure 2. Body weight changes 1 year after THA 
Body weight change per BMI category 
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The ASA score did not affect the change of body weight in time ( no 
confounding or effect modification) for any patients except those who were 
obese and had an ASA score of 3. In this particular group no confounding was 
shown but effect modification was significant (95% CI = 2.2 to 8.2), resulting 
in a smaller decrease in body weight compared with patients with ASA score 
of 1 who were obese (see Figure 3) . 
Lon9-term effect efTHA on body wei9ht 
Figure 4 shows the mean (±standard error) body weight of patients 
preoperatively and 1 year and 4. 5 years postoperatively per BMI category. 
Figure 3 .  Effect modification of ASA score for patients BMI > 30 kg/m 2 1 year postoperatively 






TO = Time of surgery; TI = one year after surgery 
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The GEE analysis of the long-term effect of THA on body weight showed no 
change in body weight in the group of patients who were of normal weight 
and the group of patients who were overweight, but a significant decrease of 
6 . 2  kg of body weight for those patients who were obese (95% CI = -9 .0  to 
- 3 . 5 ) ,  which corresponds to a 6 .4% weight loss. The GEE analysis showed no 
confounding or effect modification by sex or age at surgery, for the change of 
body weight in time ( data not shown) . 
The ASA score did not affect the change of body weight in time (no 
confounding or effect modification) for any patients except those who had a 
normal weight and an ASA score of 3 .  In this particular group no confounding 
was shown but effect modification was significant (95% CI = - 8 . 2  to -2 .4) ,  
resulting in a prominent decrease in body weight compared with who has a 
normal weight and an ASA of 1 ( see Figure 5 ) .  
Figure 4 .  Body weight changes 1 and 4.5 years afterTHA 
Body weight change per BMI category 
1 20 �------------- --------------. 
D Preoperati\'cly 
1 10  ■ Postoperatively I year 
■ Postoperatively 4.5 years 
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Figure 5.  Effect modification of ASA score for patients with BMI < 25 kg/m2 4.5 years postoperatively 
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TO = Time of surgery;TI = I year after surgery;T4.5 = 4.5 years after surgery 
Discussion 
The results of this study show that 1 (short-term) as well as 4. 5 years (long­
term) after THA there is no 5% clinically relevant reduction in body weight 
compared to preoperative body weight, except for patients with obesity in 
the long-term group. In addition, body weight change was influenced by an 
ASA 3 status, which led to a more apparent decrease in obese patients after 
1 year compared with patients with an ASA 1 status who were obese. The same 
pattern in body weight was seen in normal-weight patients with an ASA 3 
status in the long-term group compared with patients with ASA 1 status who 
were of normal weight. 
The results of our study are in line with existing literature about 
weight change after THA surgery, which shows an increase or no change at 
all. 1 2• 1 8•2 1  Although weight reductions were found in  our research, they were 
small and considered not clinically relevant, with the exception of the patients 
with obesity in the long-term follow-up group. This latter finding is not seen 
in the study of Dowsey et al. (2010), 20 which categorized a study population 
of 471 patients into non-obese (BMI <30 kg/m2) ,  obese (BMI 30-40 kg/m2) 
and morbidly obese (BMI >40 kg/m2) groups. In that study the obese group 
gained 0. 7 kg in 1 year, whereas in our study the obese group lost 3. 2 kg in 
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1 year. The proportion of men and women in the study group was comparable 
to ours; therefore it provides no explanation for the differences in results . 
The contradictions in weight change in both studies could be explained by the 
different numbers of patients who are morbidly obese and the way they 
are categorized. In our study the percentage of patients who are morbidly 
obese was only 1 .6%, so we did not categorize this specific group separately, 
whereas in the Dowsey et al . study 8% were morbidly obese. Vincent and 
colleagues stated that patients who are morbidly obese need far more 
time and effort for rehabilitation and subsequently to achieve physical 
improvements than patients who have less body mass, 27 which can have an 
effect on losing weight. 
Aderinto et al . 1 9  examined a long-term (3 years) effect of THA 
surgery on body weight change . They categorized their study group of 140 
patients into nonobese (BMI < 30 kg/m2) and obese (BMI � 30 kg/m2) 
groups. Their obese group (n=59) showed an increase in body weight of 
4 kg in 3 years. Again, this finding is in sharp contrast to our results of losing 
6 kg after 4 .5  years in the obese group (n=31 ) .  Cultural, sex (in Aderinto's 
and colleagues' study 55% were women; in our study 67%) and group size 
differences aside, we have no explanation for this contrast . 
In a study by Middleton and Boardman 1 2 all patients had an increase 
in body weight, unlike the outcomes of our study. Middleton and Boardman 
examined the change of BMI, instead of body weight, two years after a THA 
surgery. It was not stated clearly, however, what had been the indication for 
surgery (OA, fracture, or other reasons) or whether there were comorbidities 
at the time of surgery, both of which could influence the outcome of the hip 
arthroplasty and subsequently a possible change in weight . 
The finding in our study that sex and age at the time of surgery 
were no confounders or effect modifiers is in agreement with the findings of 
Aderinto et al . 19 and Dowsey et al . 20 • They showed that neither age nor 
sex predicted weight change after a primary THA. However, Dowsey et al . 
concluded that comorbidities had no association with weight change after a 
primaryTHA either. This finding is in contrast to our finding that patients with 
a preoperative ASA score of 3, indicating severe systemic diseases, present a 
different course of the weight change than patients with normal weight and 
obesity. For the patients who are obese, the smaller decrease in body weight 
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was not unexpected, as being obese and having severe systemic diseases at 
the same time probably makes losing weight more difficult . In the patients 
who were of normal weight, there was a decrease in body weight, which was 
not expected and certainly not aimed for in this subcategory. An explanation 
of this difference in outcome between our study and the study of Dowsey et 
al . can lie in how comorbidities were measured and defined . Dawsey et al 
categorized the comorbidities as diabetic, cardiovascular or respiratory 
types. 20 No information about the severity of these comorbidities at the time 
of surgery was mentioned .  More research would be advisable ,  especially 
among patients of normal weight combined with comorbidities at the time 
of surgery, to gain insight into determinants of this phenomenon and to avoid 
undesirable weight loss . 
Strengths and limitations 
The large study group and the long-term follow up of 4 . 5  years were major 
strengths of this study. Because of the difficulties in explaining why weight 
gain or weight loss occur in this type of research, we also consider it a 
strength to have taken the baseline BMI and comorbidities into account when 
analysing our results. Another strength was the sourcing of patients from 
3 different types of hospitals ,  which limits the risk of selection bias and 
improves generalizability of results. 
The most prominent limitation of the study was that height and weight -
and thus BMI - were self-reported. This limitation probably leads to an 
underestimation of the problem, as it is known that people tend to 
underestimate their weight and overestimate their height. 28 This 
underestimation is a well-described phenomenon in populations with 
varying characteristics . 29-3 1 However, it also can be argued that despite the 
supposed underestimation of weight, this study showed that no clinically 
relevant changes in body weight occurred except in the long-term follow-up 
group of patients who were obese . This underestimation could also explain 
the differences found in the results of this study compared to other studies . 
Although not clinically relevant (with the exception of the obese group on the 
long term) , the results of this study did show minor reductions in body weight 
in contrast to earlier studies , in which no changes at all or even increases 
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physically active. In these recommendations it is argued that preventive as 
well as therapeutic recommendations should be integrated into postoperative 
rehabilitation programs. As part of the postoperative rehabilitation process 
both the orthopaedic surgeon and the physical therapist can play an important 
role. The orthopaedic surgeon can act as a powerful motivational figure in 
stimulating an active lifestyle. 32 • 3 3  As the physical therapist is in charge of the 
postoperative rehabilitation and most patients visit the therapist frequently, he 
can play a central role in stimulating an active lifestyle, possibly in cooperation 
with a dietician to support weight reduction in patients afterTHA. 
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et al. (2010) clearly described that a health professional measured weight 
and height. The other studies report that weight and height were recorded 
preoperatively, yet do not describe how these data were collected. 
A further limitation of this study is the fact that no information 
was available about the intensity and types of exercise or physical activity 
or the nutritional changes of the participants. The fact that this study was 
conducted in the Netherlands can also be considered as a limitation. In con­
trast to other Western countries (e.g. the United States), in the Netherlands 
walking and bicycling are widespread methods of transportation, even for 
persons after a THA. This cultural aspect may limit the generalizability of the 
results. 
Finally, it must be remarked that large standard deviations were 
evident in body weight in this study. This is illustrated by the fact that the obese 
subgroup followed over 4. 5 years showed a higher baseline body weight (97. 3 
kg) compared to the entire obese group pre-operatively (9 3 .  2 kg). However, 
the long-term follow-up subgroup was not significantly different regard­
ing preoperative BMI categories compared with the larger group of patients 
followed up at 1 year. Moreover, if we consider the 9 3. 2 kg baseline weight 
of the entire obese group (instead of the 97. 3 kg recorded by the smaller 
subgroup of obese people followed long term), we can still see a decline in 
body weight on the long term and certainly no increase. Overall it can be 
concluded that more research is needed to gain further insight into the 
long-term effect of THA on body weight. 
Conclusion/ Implications 
From the results of this study it can be concluded that in the short as well as 
long term there is no clinically relevant reduction of weight afterTHA, except 
for patients who are obese in the long term. Consequently, it can be argued 
that both for the survival of the prostheses and for general health gains, people 
after a THA should be encouraged to lose weight . From that perspective it 
can be suggested that weight management should be included as a compo­
nent of postoperative rehabilitation if the patient is overweight or obese. This 
suggestion is in line with the physical activity recommendations by the Ameri­
can College of Sports Medicine (2007) for older adults, which state that older 






Due to an aging society and the epidemic of overweight/ obesity, the 
incidence of people with hip osteoarthritis (OA) and consequently the 
number of those who need a total hip replacement (THA) is growing. 1 • 2 
However, earlier research on conservative treatment for OA has focussed 
primarily on knee OA. In this thesis the focus of research was hip OA, both in 
the preoperative ( conservative treatment) and in the postoperative phase. In 
both phases the role of physical activity and weight loss were analysed. 
The general practitioner (GP) plays an important role in the 
preoperative phase. Chapters 2 and 3 analysed the time until referral to 
orthopaedics and the GP's management in this period. As the management of 
the GP can be mirrored to existing guidelines, an overview will be given of 
the available national and international recommendations. 
Secondly the role of physical activity and exercise will be discussed 
in the context of 'Exercise is Medicine' , a concept that originates from the 
United States. It conceptualizes a proactive attitude in which sports medicine 
is introduced into the curriculum of family practice. In Chapters 4 and 5 the 
role of physical activity/ exercise in the conservative treatment of hip OA was 
analysed, and additionally Chapter 6 presented an analysis of the influence of 
overweight/ obesity on physical functioning and health-related quality of life 
after THA. The results of these studies are discussed within the context of 
'Exercise is Medicine' . 
This chapter ends with clinical implications and ideas for future 
research. In the clinical implications section the results of the studies in this 
thesis and the thoughts from the discussion are translated into implications for 
the treatment of hip OA in clinical practice. Ideas are postulated for future 
research in order to improve both the conservative treatment of hip OA 
patients by means of physical activity/ exercise and diet interventions, and the 
health and lifestyle of OA patients afterTHA. 
The policy of general practitioners 
In the Netherlands, patients with hip OA first go to their general practitioner. 
Once the symptoms worsen beyond the GP's treatment options, the patient 
is referred to the orthopaedic surgeon to discuss further treatment. The 
moment that a patient switches from primary to secondary care is on 
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average seven years after the diagnosis is set ( Chapter 2). This is a considerable 
amount of time during which a GP manages the complaints and symptoms of 
the hip OA patient. Our research into G Ps' medical care during this primary 
care period ( Chapter 3) showed that the management consists mainly of pain 
medication or a wait-and-see policy. It is assumed that this policy consists of 
lifestyle advice. However, because no data on GP-patient communication was 
available and could therefore not be retrieved, this remains speculative. 
Regardless of the fact that no specific OA guidelines for GPs are 
available in the Netherlands, the GP could base his treatment policy on other 
national and international recommendations. Recommendations on lower 
limb OA published by three prominent international bodies can be found in 
the literature: the EULAR, 3 • 3 •4 ACR,4 and OARSl5 guidelines. 
The EULAR guideline represents 14 European countries whose 
development group comprised 18 rheumatologists, 4 orthopaedic surgeons 
and one epidemiologist. EULAR stands for European League Against 
Rheumatism and describes the optimal management of hip OA by 
combining non-pharmacological and pharmacological treatments. According 
to EULAR, this non-pharmacological treatment should include education, 
exercise, equipment and weight reduction if necessary. EULAR also states 
that the treatment must be tailored according to risk factors, level of pain and 
disabilities, location and structure damage, and the wishes of the patient. 
The American College of Rheumatology (ACR) guidelines join 
in the perspective of combining non-pharmacological interventions with 
pharmacological ones, but claims that non-pharmacological interventions 
should be perceived as a base upon which pharmacologic interventions should 
be built. These ACR guidelines were first presented in 199 5 for knee and 
hip OA separately, with updates following in 1998, 2000 and 2002 which 
predominantly concerned more insights into pain medication treatment. 
However knee and hip OA were not discussed separately in these updates. 
In 2008 Osteoarthritis Research International (OARS!) produced 
a recommendation for the management of knee and/ or hip OA. Their 
guideline development committee was composed of 16 experts from four 
medical disciplines (2 GPs 2, 11 rheumatologists, one orthopaedic surgeon 
and two evidence-based medical professionals) representing six countries 
in Europe and North America (France, Netherlands, Sweden, UK, Canada 
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and USA). OARS! also stresses that the optimal management of OA requires 
a combination of non-pharmacological and pharmacological modalities, 
without specifying its recommendations for hip or knee OA. Non­
pharmacological modalities in their opinion consist of information access and 
education for lifestyle changes, exercise, pacing of activities, weight reduction 
and other measures to unload the damaged joints. OARS! states that the 
initial focus should be on self-help rather than passively delivered therapies by 
health care professionals. OARS! also emphasises encouraging adherence to a 
regimen of non-pharmacological therapy. In 2010 an update of evidence 
on the benefits and harms of new and existing therapeutic options for the 
treatment of the hip and knee was published. This update revealed no change 
in effect size for self-management, education and acupuncture in pain relief, 
but an increased effect size concerning weight reduction and consequently 
pain relief for hip and knee OA patients. 6 
In the Netherlands two recommendations are available for the 
management of lower limb OA: the Dutch Institute for Healthcare 
Improvement CBO guideline 7 and the Royal Dutch Society for Physical 
Therapy (KNGF) guideline. 8 The CBO guideline development committee 
was composed of 2 rheumatologists, 6 orthopaedic surgeons, 2 
physiotherapists, 2 radiologists, 2 CBO advisors, one orthopaedic scientist 
and a general practitioner. The CBO guideline, a document created by the 
Dutch Orthopaedic Society for patients with knee and/ or hip OA, was 
published in 2007. The KNGF guideline was published in 2001 with the help 
of 8 physiotherapists, 3 epidemiologists, a movement scientist and a professor 
of paramedical care, and was developed for knee and/ or hip OA. Both these 
guidelines advocate the prescription of exercise aimed at improving function 
and decreasing pain symptoms as well as losing weight in case of overweight 
or obesity. The CBO guidelines however expand this recommendation with 
the prescription of pain medication. 
While Dutch GPs have no specific GP guideline (NHG standaard) 
for the treatment of OA of the hip, it can be assumed that they use shared 
knowledge of other disciplines, national and international. Both exercise and 
weight loss are mentioned in these guidelines. However these treatment mo­
dalities were not encountered in our study as presented in Chapter 3. There 
is a possibility that these treatment modalities were advised to patients rather 
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than prescribed; although many observations were done by the GPs some 
of them were not listed in their recording system, like verbal advice, and 
could therefore not be measured in our study. Specific therapeutic modalities 
such as dietary guidance or physiotherapy would have been noted, and these 
were infrequently (like physiotherapy) or never (like dietary guidance) 
encountered in our observations. In conclusion, there is disagreement 
between the existing guidelines and the management of Dutch GP. This 
disagreement could be explained by the possibility that GPs do not consult 
foreign guidelines or do not consider national guidelines of other disciplines, 
which in their opinion are not applicable for their own discipline. Another 
explanation could be unfamiliarity with the notion of exercise as a medical 
treatment. These factors underline the importance of developing Dutch GP 
guidelines (NHG standaard) in which such exercise as a medical treatment 
should be described. 
Exercise is Medicine 
Physical activity, as shown in this thesis, can play an important role both in 
the conservative treatment of hip OA as well as after a THA in maintaining a 
healthy lifestyle and more particularly a healthy weight. The beneficial effects 
of physical activity have been described elaborately in past decades, with an 
increasing understanding of how physical activity can affect the physiological 
function of the body and of how it can cause a number of health benefits. As 
a consequence of this knowledge, the concept 'Exercise is Medicine' evolved 
in which the beneficial effects of integrating physical activity as a treatment 
modality in a diversity of diseases is described. 9• 1 1  
Physical activity, health and physical fitness are related concepts, 
a connection that is well presented in the Toronto model of Bouchard. 1 2 • 1 3  
Physical activity in this model is defined as bodily movement produced by the 
contraction of skeletal muscle that increases energy expenditure above ba­
sal level. 14 A subcategory of physical activity is exercise, which is a 'physical 
activity that is planned, structured, repetitive, and purposive in the sense 
that improvements of physical fitness is the objective' . Considering physical 
fitness the general accepted definition is ' the ability to carry out daily tasks 
with vigour and alertness, without undue fatigue, and with ample energy 
to enjoy leisure-time pursuits and to meet unforeseen emergencies' . In the 
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literature the terms 'health-related fitness ' and 'performance-related fitness' 
can be encountered, both of which should be seen as subcategories of physical 
fitness. The first, 'health-related fitness ' ,  refers to those fitness components 
that are affected favourably or unfavourably by physical activity and relate 
to health status. It includes cardiorespiratory fitness, muscular strength and 
endurance, body composition and flexibility. The second, 'performance­
related fitness ' ,  comprises fitness components that are necessary for optimal 
work or sports activity. 1 5  Health is defined by Bouchard as a human condition 
with physical, social and psychological dimensions, each characterised on a 
continuum with positive and negative poles. Positive health is associated with 
a capacity to enjoy life and withstand challenges, and not merely the absence 
of disease. 1 3 
Based on the Toronto model it can be argued that both health and 
fitness benefits can be achieved by means of physical activity. The health 
benefits can be shown in primary (reducing the development of disease), 
secondary ( early detection and treatment to minimise morbidity) and tertiary 
(reduction of disease-related complications and restoration of function) 
effects. 1 1  For example, regular physical activity can reduce the risk of 
developing Alzheimer's disease, reduce the incidence of heart disease and high 
blood pressure, lower the risk of stroke and of developing type-II diabetes, 
and possibly lower the risk of colon cancer by over 60% and reduce mortality 
and the risk of recurrent breast cancer by approximately 50%. 1 6  In addition, 
exercise is one of the best stress relievers, 17 and greatly reduces a patient's 
reliance on antidepressant medication. 18 The benefits of physical activity in 
primary, secondary and tertiary disease effects aside, the benefits of regular 
physical activity are also shown at the physical fitness level, in the increase 
of older adults ' ability to perform their daily activities, thereby promoting 
independence and enhancing their quality of life. 1 9 
On the other hand, physical inactivity is associated with a negative 
effect on health and fitness. It is linked to premature death overall as a result 
of specific chronic diseases such as coronary heart disease, colon cancer and 
non-insulin dependent diabetes. 20•2 1  Physical inactivity was classified in 2000 
as the second cause of death within the modifiable behavioural risk factors as 
causes of mortality (400,000 deaths; 16.6%) in the United States. 2 1 In 2008 
the estimates of age-adjusted rates of leisure-time physical inactivity in the 
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United States ranged from 10.1 % to 43.0%.22 In the Netherlands 44% of the 
population aged 12 and older was insufficiently active in 2007. 23 
An additional effect of an increasingly physically inactive lifestyle in Western 
society is the higher numbers of people with overweight or obesity. While 
since the 1970s the amount of energy consumed through food has not 
changed considerably, energy expenditure in terms of exercise and physical 
activity has decreased, parallel to an increase in obesity. This low daily energy 
expenditure in Western culture can be explained by the characteristics of 
modern living, 24 less occupational energy expenditure, 25 and the increasing 
popularity of leisure-time computer usage. 26•2 7  In OA, a high BMI is 
considered a risk factor in the development of the disease. 28 
Exercise is Medicine in the conservative treatment ef hip OA 
Physical activity can play an important role both in the conservative treatment 
of hip OA and after a THA in maintaining a healthy lifestyle and more 
particularly a healthy weight. Exercise is safe and well tolerated by most 
patients with lower limb OA, and is proven to be effective in the 
conservative treatment of knee and hip OA for decreasing pain and 
increasing physical function. 29 In a review of Bennell and Hinman in 2011 
it was concluded that exercise is a key component in the management of 
symptoms of knee and hip OA, and that encouraging exercise adherence 
behaviours and reinforcing healthy lifestyle habits will assist in optimising 
outcomes from treatment. 30 A study of Swank et al. 3 1  also stressed the 
benefits of exercise for knee OA patients who are awaiting surgery, in order to 
improve their recovery in terms of postoperative performance of functional 
tasks. 32•34 
Weight loss can also play an important role in the conservative 
treatment of OA of the hip. From a general health perspective it is known that 
weight loss imbedded in a lifestyle change markedly improves cardiovascular 
risk and the metabolic profile, and this improvement can be sustainable in 
hypertensive, coronary heart disease and diabetic patients. Weight loss 
interventions in overweight/ obese older subjects led to significant benefits 
for those with coronary heart disease, and those with type-2 diabetes 
mellitus. 20,35 -37 Modest weight loss (5-10% of initial weight) has positive 
effects on BP, cholesterol and glucose levels. 38-40 Substantial weight loss 
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(15-20% of initial weight) can reverse type-2 diabetes risk within one 
year of diagnosis. 40•4 1  Even for persons with serious mental illness there are 
indications that they can benefit from short-term behavioural weight loss 
interventions.42•43 Weight loss is proven to be effective in knee OA patients 
before joint replacement by improving physical function;44 46 a weight 
reduction of 10% leading to an improvement of function of 28% has been 
reported . 
The combination of physical activity/ exercise and diet in order to 
lose weight is often advised to maximise the effect . The literature shows 
how this combination is effectively applied in healthy obese men, leading to 
improved breathing mechanics during submaximal exercise, 47 and in infertile 
and overweight women who increased their ovulation rates and 
chances of pregnancy. 48 In the orthopaedic setting obese patients with knee OA 
showed, after a combined therapy of exercise and weight loss, better overall 
improvements in physical function, pain and mobility compared to either 
therapy separately. 49 Additionally, in Chapter 5 of this thesis an indication is 
given of the positive effect of this combined therapy in hip OA patients: the 
effect on self-reported physical function showed an improvement of 32%, 
measured with the WOMAC questionnaire; and objective physical function, 
measured with the 6-minute walking test, showed an improvement of 11. 1  % 
compared to baseline after 8 months of exercise by strengthening the muscle 
power of the damaged joint and training stability, and losing weight by means 
of aerobic exercise and diet . These outcomes together with the 
aforementioned benefits of exercise or physical activity on other diseases 
and on overall well-being by increasing health and fitness should elicit health 
care specialist like orthopaedic surgeons, GPs and physiotherapists to include 
these treatment modalities more often, and to increase chances on an optimal 
result, to combine both exercise and weight loss. 
Exercise is Medicine efter a THA 
After arthroplastic surgery it is agreed on that immediate but gradual weight 
bearing on the operated joint is necessary for improvement of bone quality 
and prosthetic fixation50 and also to motivate patients to remain physically 
active after joint replacement. Additional benefits of physical activity are 
recognised for achieving general health, and in particular creating or 
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maintaining a healthy body weight. Such a healthy body weight after 
arthroplastic surgery is essential for implant stability. 5 1 •5 2  Furthermore, Roder 
et al. 53 showed that each extra unit of BMI increases stem loosening odds. In 
this case, losing weight after hip surgery would imply better survival odds of 
the implant. Obese patients tend to claim that the OA in their joints limits 
their ability to perform physical activities and consequently to lose weight, 
but that they will become physically active again once they have a prosthesis , 
which restores function and reduces the pain. This was also assumed in our 
study as described in Chapter 7. Although there was weight loss, it was limited 
and not clinically relevant. Especially in overweight/ obese patients with 
preoperative comorbidities, the amount of weight loss after surgery was 
minimal. It can be concluded that these results are in line with earlier research 
on this issue, which shows an increase or no change at all. 54-5s However, as 
shown in Chapter 6 of this thesis it is of great importance to account for 
complications and comorbidities ,  as the impact of these factors on physical 
functioning is considerable. 
As a higher BMI has shown to be associated with lower physical 
activity in patients after total hip arthroplasty, 59 physical activity programs are 
needed for overweight and obese patients following total joint arthroplasty. 
Such programs should aim at increasing energy expenditure and lowering 
body weight, but preferably be applicable to each specific patient, with or 
without complications or comorbidities. 
Exercise is Medicine initiatives 
The concept of 'Exercise is Medicine' originates from the United States, 
where a proactive attitude is conceptualised by introducing sports medicine 
into the curriculum of family practice residencies and by launching an 
'Exercise is Medicine' program (and a website) for senior health care 
providers. 60 In the Netherlands there is also a growing awareness of the 
concept of 'Exercise is Medicine' , which can be exemplified by the PACE 
project. PACE stands for Physician-based Assessment and Counselling for 
Exercise. 6 1 •62 Originally developed in the United States, it was designed to be 
incorporated into general practices within diverse patient populations. PACE 
aims at promoting the adoption of long-term participation in regular physical 
activity and assists providers in overcoming barriers to counselling patients 
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about physical activity. Research into the practical application of this program 
in adults with hypertension and/ or hypercholesterolaemia and/ or non­
insulin-dependent diabetes in the Netherlands62 has shown that the program 
was acceptable and feasible for a selected number of general practices. Based 
on these outcomes adaptations will be made in order to implement it success­
fully on a wider scale. 
Beweegkuur (Dutch for 'Exercise Therapy') is a more recent 
development. 63 This lifestyle intervention was initially developed for diabetic 
and prediabetic patients, but later on expanded into an intervention for all 
those patients who have a high BMI with an additional weight-related health 
risk. The intervention aims at both physical activity and dietary behaviour 
changes, and includes multiple health disciplines to achieve this. It is 
structured as an organised interaction between GP, practice nurse, 
physiotherapist and dietician; however, the role of the physiotherapist in this 
intervention can also be taken over by a lifestyle advisor or an exercise coach. 
Results after one year showed that patients were motivated by Beweegkuur 
to increase their physical activity or to maintain their activity level. The most 
mentioned reason to join Beweegkuur was to lose body weight; additionally 
the secure exercise environment was mentioned because of the professional 
guidance to exercise safely. Results concerning the national implementation 
of the program showed some practical points on the specific role of each 
health professional and time management in general practice. Regardless of 
these practical points, in this first year of Beweegkuur seven regions of the 
Netherlands were involved; the aim of Beweegkuur Is to implement this com­
bined intervention throughout the country by 2012. 
Within orthopaedics a lifestyle intervention was developed at the 
Department of Orthopaedics of UMCG, called Orthopaedic Physical 
Activity Counselling (OPAC). In this intervention patients were counselled 
multiple times postoperatively about their physically active lifestyle and 
their body weight. A pilot study was conducted to get an impression of the 
feasibility of incorporating this counselling into regular postoperative 
medical consultations. This study showed a positive attitude toward OPAC by 
both medical staff and patients; the clinical feasibility of the intervention was 
questioned because of time constraints though. 
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These three Dutch initiatives show the growing awareness of exercise 
as medicine. The results of this thesis emphasise that this awareness should also 
be applied to hip OA and THA patients. 
Clinical implications 
From the results of this thesis it can be concluded that Dutch GPs should be 
supported in their treatment policy of hip OA by a national hip OA guideline 
for GPs (NHG standaard) that should include exercise and weight loss. Is 
therefore it is important that this development is given priority. Once this 
guideline is at GPs' disposal it is also critical to stimulate its use, particularly 
the prescription of weight loss for overweight or obese patients and the 
prescription of exercise as medicine. 
Based on the 'Exercise is Medicine' concept integration should be 
promoted of rehabilitation and preventive recommendations for health­
enhancing physical activity after a THA, in which rehabilitation advice should 
turn gradually into a tailored lifestyle advice. This suggestion is in line with 
the latest recommendations for health-enhancing physical activity for older 
adults, 64 which recommend that older adults should perform moderate­
intensity aerobic (endurance) physical activity for 30 minutes or more at least 
5 days per week, or vigorous-intensity aerobic physical activity for a minimum 
of 20 minutes at least 3 days per week, in addition to muscle-strengthening 
activity, This integration of recommendations is important because after a 
THA it is not only essential for patients to restore their physical function but 
also to adopt a physically active lifestyle, from a health perspective as well as 
from a physical fitness perspective. Older adults are not only faced with the 
occurrence of chronic conditions but also with a decline of a number of func­
tions associated with aging that can threaten their independent performance 
of activities of daily living and consequently their quality of life. 
Future research 
To build on the results of the cohort study of our thesis, additional research 
about the clinical effects of exercise combined with weight loss 
interventions in hip OA patients should be conducted in a randomised 
controlled trial (RCT). In addition, more research is needed on both the 
optimal content of the exercise and weight-loss program and on the 
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combination of programs. 
Research is also needed into the development of rehabilitation 
programs for THA patients. In addition to already existing programs, new 
programs should include weight loss and take into account pre-existing 
comorbidities, while until now rehabilitation programs for hip arthroplasty 
only focus on accelerating the restoration of physical function by passive or 
active mobilisation . 
More insight is also needed into the long-term effects of a THA on 
weight loss. While the first indications shown in this thesis are promising, the 
long-term effects of a THA on weight are still not clear and should be studied 
more thoroughly. 
Finally, the implementation of rehabilitation programs and the 
'Exercise is Medicine' concept should be investigated more deeply. 
Although the clinical feasibility of OPAC was questioned, it was evaluated 
positively within the orthopaedic setting. Continuous monitoring of hip OA 
patient by a health care professional seems advisable and should be the object 
of further study. Although performed in another setting, the study of Barte et 
al . ,  66 in which the study participants in the intervention group had lifestyle 
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The Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC). 
Pijn  en Lichamel ijk  Functioneren 
PIJN 
De volgende vragen gaan over de hoeveelheid pijn die u op dlt moment ondervindt als gevolg 
van de artrose in uw heup. Voor ieder van de onderstaande vragen moet u aangeven 
hoeveel pijn u recent heeft ondervonden. 
KRUIS EEN RONDJE PER VRAAG AAN 
Hoeveel pijn heeft u bij: geen gering matig ernstig zeer 
ernstig 
Lopen op een vlakke ondergrond 0 0 0 0 0 
Trap op of af lopen 0 0 0 0 0 
Gedurende de nacht in bed 0 0 0 0 0 
Bij zitten of liggen 0 0 0 0 0 
Het recht op staan 0 0 0 0 0 
GEWRICHTSSTIJFHEID 
De volgende vragen hebben betrekking op de hoeveelheid gewrichtsstijfheid die u op dit 
moment ondervindt. Stljfheid is een gevoel van beperking of vertraglng in het gemak 
waarmee u uw gewrichten beweegt. 
KRUIS EEN RONDJE PER VRAAG AAN 
geen gering matig ernstig zeer 
ernstig 
Hoe stijf bent u 's ochtends bij het 0 0 0 0 0 
opstaan? 
Hoe stijf bent u later op de dag 0 0 0 0 0 





De volgende vragen hebben betrekking op uw lichamelijk functioneren. H iermee wordt het 
gemak bedoeld waarmee u zich voortbeweegt en de mate waarin u voor zichzelf kunt 
zorgen. Voor elk van de volgende vragen verzoeken wij u aan te geven in welke mate u 
wordt beperkt als gevolg van de artrose in uw heup. 
KRUIS EEN RONDJE PER VRAAG AAN 
Hoeveel moeite heeft u bij : geen gering matig veel erg veel 
De trap aflopen 0 0 0 0 0 
De trap oplopen 0 0 0 0 0 
Opstaan vanuit een steel 0 0 0 0 0 
Staan 0 0 0 0 0 
Voorover buigen naar de vloer 0 0 0 0 0 
Lopen op een vlakke ondergrond 0 0 0 0 0 
In en uit de auto stappen 0 0 0 0 0 
Het gaan winkelen 0 0 0 0 0 
Sokken of panty's aantrekken 0 0 0 0 0 
Het uit bed opstaan 0 0 0 0 0 
Sokken of panty's uittrekken 0 0 0 0 0 
In bed liggen 0 0 0 0 0 
In of uit bad stappen 0 0 0 0 0 
Zitten 0 0 0 0 0 
Op een toilet gaan zitten en weer 0 0 0 0 0 
opstaan 
Zwaar huishoudelijk werk 0 0 0 0 0 
Licht huishoudelijk werk 0 0 0 0 0 
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Osteoarthritis (OA) is a chronic musculoskeletal disease that predominantly 
affects weight-bearing joints such as knees and hips. As for hip OA, it is 
recognised as a substantial source of disability, with pain and loss of function 
as principal symptoms. In addition to an aging society, the increasing number 
of overweight and obese persons will also give rise to a higher prevalence of 
hip OA. This thesis focuses on the role of physical activity and losing weight in 
hip OA, in the preoperative phase ( conservative treatment) as well as in the 
postoperative phase (after hip replacement) . 
Chapter 1 is the general introduction of this thesis, describing four objectives .  
The first objective of this thesis is  to study the treatment policy of the general 
practitioner, and more specifically to what extent weight loss and/ or exercise 
play a role in the conservative treatment of OA of the hip. The second objective 
is to study the effect of a combination treatment of weight loss and exercise 
in hip OA patients. The third objective is to analyse the effect of overweight/ 
obesity on patient-perceived physical functioning and health-related quality of 
life one year afterTHA, taking into account the influence of co morbidity and 
preoperative complications. The final objective of this thesis is to determine 
to what extent a THA leads to weight loss in hip OA patients categorised into 
normal weight, overweight and obese, as well as to determine the long-term 
effect of a THA on body weight. 
Chapter 2 presents the time a hip OA patient spends at the GP's practice before 
the patient is referred to an orthopaedic specialist. Patients aged 1 8  or older 
with the diagnosis of hip OA were included, and analysed in a prospective 
observational study based on data over a 1 0-year period from a general 
practice-based registration network ( 1 7  GPs, > 30,000 patients registered 
yearly) . Of 39 1 patients diagnosed with hip OA, 1 2 1  (3 1 %) were referred . 
The average survival time until referral was 8 2 . 0  months. 
Chapter 3 focuses on the description of the frequency and nature of GP 
medical care, and the establishment whether this care meets national and 
international guidelines for treatment of hip OA. The same registration 
network as mentioned in Chapter 2 is used . Patients aged 1 8  years and older 
who were diagnosed with hip OA in the period between January 1 999 and 
December 2007 were selected. GP contact data was gathered 1 year before 
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and 1 year after diagnosis (total follow-up (TFU)). During the TFU the GP 
intervened in almost half of the patients. About a third had no contact with 
the GP at all. Of the 192 patients who received an intervention, 26% had 
a referral to orthopaedics. The combination of pain medication and physical 
therapy or the combination of physical therapy and a diet, as proposed by the 
guidelines, was applied in 9. 9% of the cases. 
In order to get a first impression of the potential effectiveness of a combina­
tion program of exercise and weight loss on overweight and obese patients 
suffering from hip OA, the design of a cohort study is presented in Chapter 
4. Patients aged 25 or older, overweight (BMI > 25 kg/m2) or obese (BMI 
> 30 kg/m2), with clinical and radiographic evidence of OA of the hip, and 
able to attend exercise sessions, were included. Primary outcome was self­
reported physical functioning. Patients were also evaluated using objective 
measurements, which included the 6-Minute Walk Test (6MWT). 
Additionally, weight loss in kilograms and percentage of fat-free mass were 
measured. Treatment effects were compared at all measurement points 
(baseline, after 3 months and after 8 months when the intervention program 
was finished). 
Chapter 5 presents the outcomes of the cohort study. Thirty patients with hip 
OA aged 25 years or older were analysed. Participation in the combination 
program resulted in a clinically relevant improvement of self-reported 
physical function. In addition, significant improvement was seen in walking 
ability as an objective measure of physical function. There was a significant 
decrease in body mass of 2.8 kg (3 months) and 5.6 kg (8 months) compared 
to baseline. Body fat was 41.0% at baseline and showed a significant reduction 
of 3. 3% in 8 months. The results of this study show that exercise and weight 
loss as a combination treatment seem to be effective in hip OA patients. 
In Chapter 6 a retrospective analysis of prospectively collected data from 65 3 
patients who had undergone a primary THA was conducted, to determine to 
what extent overweight/ obesity is associated with physical functioning and 
health-related quality of life after a THA. Physical functioning, health-related 
quality of life, body mass index (BMI), co morbidity and postoperative 
complications were assessed by means of a questionnaire and from medical 
records. The results show that the influence of overweight/ obesity on 
physical functioning and health-related quality of life is low. The impact of 
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complications and co morbidity however is considerable. Especially the 
combination of factors can rapidly lead to clinically relevant differences. 
Therefore it does not seem justified to refuse a patient a THA solely on the 
basis of overweight or obesity. 
Chapter 7 presents the analyses of the short- ( 1 -year) and long-term (4.5-
year) effects of a THA on body weight. For the short-term effect all patients 
(N=61 8) were analysed, for the long term a random subgroup (N= l O0). 
Pre- and postoperative body weight and height were self-reported. The 
mean age of the study group was 70 years (SD 8), 74% were women, mean 
preoperative body mass 79 kg (SD 1 4). Overweight and obese patients showed 
a significant decrease in body weight after 1 year, which was however not 
clinically relevant. After 4. 5 years a clinically relevant decrease was observed 
in obese patients. From the results of this study it can be concluded that in the 
short as well as long term there is no clinically relevant reduction of weight 
afterTHA, except for obese patients on the long term. 
Finally, Chapter 8 contains the general discussion in which the preceded 
studies were evaluated. It stipulates that the general practitioner (GP) still 
plays an important role in the preoperative phase of hip OA patients, and that 
Dutch GPs should be supported in their treatment policy of hip OA by the 
development and implementation of a national hip OA guideline for 
GPs (NHG standaard) that should include exercise and weight loss. It is 
therefore important that this development is given high priority. Additionally 
the general discussion focuses on the 'Exercise is Medicine' concept in 
which the integration of rehabilitation and preventive recommendations for 
health-enhancing physical activity after a THA should be promoted, and 








Artrose is een chronische aan veroudering gerelateerde musculoskeletale 
aandoening die zich voornamelijk manif esteert in de gewicht drag en de 
gewrichten zoals van de knie en de heup. Met betrekking tot artrose van 
de heup wordt deze aandoening gezien als sterk invaliderend, met pijn en 
functieverlies als primaire symptomen. Naast de vergrijzing is ook het 
toenemende aantal mensen met overgewicht en obesitas verantwoordelijk 
voor de stijgende prevalentie van artrose van de heup. Dit proefschrift richt 
zich op de rol van lichamelijke activiteit en gewichtsverlies bij artrose van de 
heup in de preoperatieve fase ( conservatief behandelen) evenals in de postop­
eratieve fase ( na heupvervanging). 
Hoefdstuk I is de algemene introductie van dit proefschrift, waarin 4 doelen 
worden beschreven. Het eerste doel van dit proefschrift is het bestuderen 
van het behandelbeleid van de huisarts, en meer specifiek in welke mate 
gewichtverlies en/ of bewegen een rol speelt in de conservatieve behandeling 
van artrose van de heup. Het tweede doel is het bestuderen van het effect 
van een gecombineerde behandeling van afvallen en bewegen in patienten 
met heup artrose. Het derde doel is het effect te analyseren van overgewicht 
of obesitas op zelf gerapporteerd lichamelijk functioneren en 
gezondheidsgerelateerde kwaliteit van leven een jaar na heupvervanging, 
waarbij rekening wordt gehouden met de invloed van co morbiditeit en 
perioperatieve complicaties. Tenslotte wordt in dit proefschrift bepaald in 
welke mate een heupvervanging leidt tot gewichtsverlies bij heup artrose 
patienten, zowel op de korte (1 jaar) als op de lange termijn (4, 5 jaar). 
In Hoefdstuk 2 is gekeken hoeveel tijd een patient met heup artrose onder 
behandeling is bij een huisarts totdat deze wordt doorgestuurd naar een 
orthopedisch specialist. Patienten van 18 jaar en ouder met de diagnose 
heup artrose werden ge1ncludeerd en geanalyseerd in een prospectief 
observationeel onderzoek. Data waren afkomstig van een medisch 
registratie netwerk van huisartsen over een periode van tien jaar ( 17 
huisartsen, > 30.000 patienten werden jaarlijks geregistreerd). Van de 
391 patienten gediagnosticeerd met heup artrose werden 121 (31 %) 
doorgestuurd. De gemiddelde tijd tot aan de verwijzing was 82.0 maanden. 
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In Hoefdstuk 3 ligt de focus het beschrijven van de frequentie en inhoud van 
de medische zorg die de huisarts verleent aan zijn of haar patienten met heup 
artrose, en wordt gekeken of deze zorg overeenkomt met de nationale en 
internationale richtlijnen voor de behandeling van heup artrose. Hetzelfde 
medische registratie netwerk als genoemd in hoofdstuk 2 werd gebruikt . 
Patienten van 18 jaar en ouder bij wie heupartrose werd gediagnosticeerd 
in de periode tussen januari 1999 en december 2007 werden geselecteerd. 
Gegevens over het aantal contacten met de huisarts werden verzameld een 
jaar voor en een jaar na diagnose (totale follow up tijd (TFU)). Tijdens deTFU 
stelde de huisarts een behandeling voor bij bijna de helft van de patienten. 
Ongeveer een derde van de patienten had geen contact gehad met de huisarts. 
Van de 192 patienten die een behandeling kregen, had 26% een verwijzing 
een orthopedisch chirurg. De combinatiebehandeling pijnmedicatie en 
fysiotherapie, of de combinatiebehandeling fysiotherapie en dietiek, zoals 
aanbevolen in de richtlijnen, werd toegepast bij 9 ,9% van de patienten. 
Om een eerste indruk te krijgen van het potentiele effect van een combina­
tie programma bestaande uit afvallen en bewegen bij heupartrose patienten 
met overgewicht of obesitas, werd een cohort studie opgezet waarvan het 
design wordt gepresenteerd in Hoefdstuk 4. Patienten van 25 jaar en ouder, 
met overgewicht (BMI > 25 kg/m2) of obesitas (BMI > 30 25 kg/m2) en 
klinisch en radiologisch bewezen heup artrose, die in staat waren een 
beweegprogramma te volgen werden gefocludeerd. De primaire 
uitkomstmaat was zelf gerapporteerd lichamelijk functioneren. Daarnaast 
werden patienten ook beoordeeld met behulp van objectieve metingen, 
waaronder de 6-minuten looptest (6MWT). Tenslotte werd het 
gewichtsverlies in kilogrammen en in percentage vetvrije massa gemeten. De 
behandelingseffecten werden vergeleken op alle meetpunten (baseline, na 3 
maanden en aan het einde van het combinatie programma (8 maanden)). 
In Hoefdstuk 5 worden de resultaten van de cohort studie gepresenteerd. 
Dertig patienten van 25 jaar en ouder met heup artrose werden geanalyseerd. 
Het deelnemen aan het combinatieprogramma resulteerde in een verbetering 
van het zelf gerapporteerd lichamelijk functioneren. Daarnaast werd een 
significante verbetering gezien in het loopvermogen als een objectieve 
maat van lichamelijk functioneren. Er was een significante afname in 
lichaamsgewicht van 2,8 kg (na 3 maanden) en 5,6 kg (na 8 maanden) ten 
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opzichte van baseline. Bij de baseline meting was het lichaamsvet 41 % en was 
er na 8 maanden een afname van 3, 3 % . De resultaten van deze studie la ten 
zien dat afvallen en bewegen als een combinatiebehandeling effectief lijkt te 
zijn bij heupartrose patienten. 
Hoefdstuk 6 laat een retrospectieve analyse zien van prospectief verzamelde 
data van 65 3 patienten bij wie een primaire heupvervanging heeft 
plaatsgevonden . Bepaald werd in welke mate overgewicht of obesitas was 
geassocieerd met fysiek functioneren en gezondheidsgerelateerde 
kwaliteit van leven na een heupvervanging. Fysiek functioneren, 
gezondheidsgerelateerde kwaliteit van leven, body mass index (BMI), co 
morbiditeit en postoperatieve complicaties werden bepaald met behulp van 
een vragenlijst en medische statussen . De uitkomsten laten zien dat de invloed 
van overgewicht of obesitas op het lichamelijk functioneren en de 
gezondheidsgerelateerde kwaliteit van leven laag is. De impact van 
complicaties en co morbiditeit daarentegen is aanzienlijk .  Met name bij een 
combinatie van factoren kan dit snel leiden tot klinisch relevante verschillen . 
Daarom lijkt het niet terecht een patient een heupvervanging te weigeren 
enkel op basis van overgewicht of obesitas. 
In Hoefdstuk 7 worden de uitkomsten gepresenteerd van de korte termijn 
(1 jaar) effecten en de lange termijn (4, 5 jaar) effecten van heupvervanging 
op lichaamsgewicht. Voor het korte termijn effect werden 618 patienten 
geanalyseerd, voor het lange termijn effect een at random subgroep (N= 100) . 
Lengte en lichaamsgewicht werden pre- en postoperatief aan de patient 
gevraagd. De gemiddelde leeftijd van de korte termijn groep was 70 jaar (SD 
8), 74% was vrouw en het gemiddelde gewicht was preoperatief 79 kg (SD 
14) . Patienten met overgewicht of obesitas lieten na 1 jaar een significante 
afname in gewicht zien, echter dit was geen klinisch relevante afname. Na 4,5 
jaar was er wel een klinisch relevante afname te zien in de groep patienten 
met obesitas. Uit de resultaten van deze studie kan worden geconcludeerd dat 
er zowel op de korte als op de lange termijn na heupvervanging geen klinisch 
relevante afname van gewicht is, behalve op de lange termijn voor de groep 
patienten die preoperatief obees zijn . 
Tot slot worden in Hoefdstuk 8 de resultaten van de voorafgaande hoofdstukken 
bediscussieerd. Hierin ligt de focus op de rol van de huisarts in de behandeling 
van patienten met heup artrose in de preoperatieve fase. Er wordt 
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geconcludeerd dat de N ederlandse huisartsen beter ondersteund zouden 
moeten warden in hun heupartrose beleid door de ontwikkeling en 
implementatie van nationale heupartrose richtlijnen voor huisartsen (NHG 
standaard) . Bewegen en afvallen zouden een belangrijke plaats moeten 
innemen in deze richtlijnen. Het is daarom van belang dat aan deze 
ontwikkeling prioriteit wordt gegeven. Tenslotte wordt ingegaan op het 
"Exercise is Medicine" concept, waarbij de integratie van revalidatie en 
preventieve aanbevelingen voor gezondheidsbevorderende lichamelijke 
activiteit na een heupvervanging zou moeten warden gepromoot, en 










Ik zou graag op deze plek iedereen persoonlijk willen bedanken voor zijn of 
haar rol in het gereed komen van mijn proefschrift, maar het is onmogelijk om 
iedereen bij naam te noemen. Daarom wil ik graag, voordat ik enkele mensen 
persoonlijk ga bedanken, iedereen die interesse toonde en mij, wanneer dat 
nodig bleek, 'een hart onder de riem stak ' ontzettend bedanken! Zander jullie 
was het nooit gelukt! 
Dr. M. Stevens, copromotor, beste Martin, allereerst wil ik jou bedanken. 
Zander jou was ik nooit zover gekomen als waar ik nu sta. Je was een super 
begeleider voor mij ; laagdrempelig, gei"nteresseerd en altijd behulpzaam als ik 
weer eens strandde. Ik wil je erg bedanken daarvoor. 
Dr. I. vd Akker-Scheek, copromotor, beste Inge, bedankt voor al je suggesties, 
het meedenken bij lastige kwesties en je altijd kritische blik op mijn 
geschreven stukken. 
Prof. dr. S.K. Bulstra, Sjoerd, en Prof. Dr. K van de Meer, Klaas, bedankt dat 
jullie mijn promoteren wilde zijn. Het traject verliep niet altijd even soepel 
maar dankzij jullie inbreng en motiverende woorden is het toch tot een goed 
einde gekomen. 
Wim, Roelien, en alle fysiotherapeuten van het PCRR, ontzettend bedankt 
voor het meewerken en meedenken bij het cohort onderzoek. Zander jullie 
inzet was dit nooit zo voorspoedig verlopen. 
Martine, toen je als student bij ons stage kwam lopen dachten we gelijk 
'deze doortastende dame, die moeten we in de gaten houden' .  Fijn dat je je 
bijdrage wilde leveren in het cohort onderzoek als dietist, en bedankt voor je 
enthousiasme hierin. 
De leden van de beoordelingscommissie, Prof . Dr. J.A.N. Verhaar, prof. Dr. 
S.M.A. Bierma-Zeinstra en prof. Dr. K. Postema, wil ik bedanken voor de 
snelle beoordeling van mijn proefschrift. 
Dr. W J. van Veen, Willem Jan, jou wil ik bedanken voor alle keren dat je me 
wilde helpen bij het analyseren van de RNG data. Meer dan eens kwam ik 
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alleen voor advies, maar ging vervolgens met een volledig uitgewerkt plan 
je kamer weer uit. Ik heh dat erg gewaardeerd en wil je daarvoor hartelijk 
hedanken. 
Dr. R.E. Stewart, heste Roy, om hij jou langs te komen voor een statistisch 
prohleem was nooit een straf. Bedankt voor je altijd warme ontvangst en 
gezelligheid, en daarnaast het keer op keer kinderlijk eenvoudig uitleggen van 
een statisch probleem . . .  
Verwijzende huisartsen, arts assistenten en artsen van de afdeling orthopedie 
(UMCG en Martini), en nurse practitioners, Alette, Natalie en Paul, ik 
wil jullie allemaal hedanken voor het telkens weer denken aan potentiele 
patienten voor mijn onderzoek. Zonder jullie hulp had ik mijn onderzoek niet 
uit kunnen voeren. 
Graag wil ik de deelnemers van het cohort onderzoek hedanken. Met een 
grote inzet en betrokkenheid hehben jullie allemaal meegewerkt aan het 
uitvoeren van looptesten en het invullen van vragenlijsten. Ik hoop dat dit 
onderzoek voor jullie een goed resultaat heeft opgeleverd en ook de motivatie 
om door te gaan met gezond hewegen. 
Collega ( en ex-collega) onderzoekers Inge R, Iris, Andrew, Oscar, Henk, 
Mathijs, en studenten Joelle en Imke. Jullie maakten het allemaal zoveel 
eenvoudiger. Dank jullie wel voor jullie gezelligheid en steun in lastige tijden. 
Yvonne en Els, waar zou een promovendus toch zijn zonder jullie? Erg hedankt 
voor het altijd klaarstaan, willen helpen en willen luisteren. Top !  
Ruth Rose, dankzij je  altijd snelle reactie en hereidheid onze stukken te 
corrigeren waren deadlines gemakkelijk te halen. Hartelijk dank daarvoor. 
Lieve Mark, na al mijn studie jaren sta je dan naast me als mijn paranimf. Ik 
hen er trots op dat ik je ken en dat ik een van je heste vriendinnen mag zijn. 
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Lieve Ida, al vanaf dag een dat ik op het UMCG kwam werken mocht ik je 
kamergenootje zijn en was het gezellig samen. Al die keren dat het onderzoek 
doen tegenviel, loodste jij me er weer door heen met je vrolijke hoofd en je 
goede grappen . Ook in persoonlijk zware tijden maakte jij dat het fijn was om 
toch te komen werken. Heel erg bedankt daarvoor! Niet voor niets dus dat ik 
je vroeg als paranimf, en super dat je 'ja '  zei. .. 
Byrgit, dank je wel voor al die jaren dat je mijn vriendin bent. Ook al liggen 
we niet altijd op een lijn, je hebt me ook tijdens deze jaren als promovendus 
altijd laten geloven dat ik goed bezig was. Je bent een schat. 
Ron, jou ken ik het kortst van al mijn vrienden, maar desondanks kan ik je 
met recht een goede vriend noemen. Deze laatste maanden waren zwaar en 
jij hebt me er met je motiverende woorden goed doorheen geholpen. Dank je 
wel dat je er voor me was. 
Wie ik natuurlijk ook wil bedanken zijn mijn lieve ouders, wie altijd achter 
me staan wat ik ook doe en wat ik ook wil bereiken. Ik houd van jullie. 
Mijn allerliefste Mello, bedankt voor al je liefde, geduld en begrip. Ik was 
niet altijd even gemakkelijk en toch bleef je me steunen in dit promotie 
traject. Bedankt dat je in me bent blijven geloven. 
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This thesis is published within the Research Institute SHARE of the 
Graduate School of Medical Sciences ( embedded in the University Medical 
Center Groningen I University of Groningen) . More recent theses can be 
found in the list below. 
Further information regarding the institute and its research can be obtained 
from our internet site: www.rug.nl/ share. 
( ( co-)supervisors are between brackets) 
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Vegter S .  The value ef personalized approaches to improve pharmacotherapy in 
renal disease (prof MJ Postma, prof GJ Navis) 
Curtze C. Neuromechanics ef movement in lower limb amputees (prof K Postema, 
prof E Otten, dr AL Hof) 
Alma MA. Participation ef the visually impaired elderly: determinants and inter­
vention (profThPBM Suurmeijer, prof JW Groothoff, dr SF van der Mei) 
Muijzer A. The assessment ef efforts to return to work (prof JW Groothoff, prof 
JHB Geertzen, dr S Brouwer) 
Ravera S. Psychotropic medications and treffic sefety. Contributions to risk assess­
ment and risk communication (prof JJ de Gier, prof LTW de Jong-van den Berg) 
De Lucia Rolfe E. The epidemiolo9y ef abdominal adiposity: validation and ap­
plication ef ultrasono9raphyy to estimate visceral and subcutaneous abdominal fat and 
to identify their early life determinants (prof RP Stalk, prof KK Ong) 
Tu HAT. Health economics ef new and under-used vaccines in developin9 countries: 
state-cf-the-art analyses for hepatitis and rotavirus in Vietnam (prof M J Postma, 
prof HJ Woerdenbag) 
Opsteegh L. Return to work efter hand injury (prof CK van der Sluis, prof K 
Postema, prof JW Groothoff, dr AT Lettinga, dr HA Reinders-Messelink) 
Lu W. Fjfectiveness ef lon9-term follow-up cf breast cancer (prof GH de Bock, 
profT Wiggers) 
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Boersma-Jentink J. Risk assessment ef antiepileptic drugs in pregnancy (prof 
LTW de Jong-van den Berg, prof H Dolk) 
Zijlstra W. Metal-on-metal total hip arthroplasty; clinical results, metal ions and 
bone implications (prof SK Bulstra, dr JJAM van Raay, dr I van den Akker­
Scheek) 
Zuidersma M. Exploring cardiotoxic effects ef post-myocardial depression (prof P 
de Jonge, prof J Ormel) 
Fokkens AS. Structured diabetes care in general practice (prof SA Reijneveld, dr 
PA Wiegersma) 
Lohuizen MT van. Student learning behaviours and clerkship outcomes (prof 
JBM Kuks , prof J Cohen-Schotanus , prof JCC Borleffs) 
Jansen H. Determinants ef HbAl c in non-diabetic children and adults (prof RP 
Stolk) 
Reininga IHF. Computer-navigated minimally invasive total hip arthroplasty; 
effectiveness, clinical outcome and gait peiformance (prof SK Bulstra, prof JW 
Groothoff, dr M Stevens ,  dr W Zijlstra) 
Vehof J. Personalized pharmacotherapy ef psychosis; clinical and pharmacogenetic 
approaches (prof H Snieder, prof RP Stolk, dr H Burger, dr R Bruggeman) 
Dorrestijn 0. Shoulder complaints; indicence, prevalence, interventions and out­
come (prof RL Diercks , prof K van der Meer, dr M Stevens, dr JC Winters) 
Lonkhuijzen LRCM van. Delay in sefe motherhood (prof PP van den Berg, 
prof J van Roosmalen, prof AJJA Scherpbier, dr GG Zeeman) 
Bartels A. Auridoiy hallucinations in childhood (prof D Wiersma ,  prof J van 
Os, dr JA Jenner) 
Qin L. Physical activity and obesity-related metabolic impairments: estimating inter­
action from an additive model (prof RP Stolk, dr ir E Corpeleijn) 
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